Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in J Crohns Colitis

Retrieve available abstracts of 412 articles:
HTML format



Single Articles


    November 2021
  1. GORDON IO, Abushamma S, Kurowski JA, Holubar SD, et al
    Pediatric Ulcerative Colitis Is A Fibrotic Disease And Linked With Chronicity Of Inflammation.
    J Crohns Colitis. 2021 Nov 29. pii: 6445941. doi: 10.1093.
    PubMed     Abstract available


  2. BAR-YOSEPH H, Blatt A, Gerassy S, Pressman S, et al
    Differential serum-intestinal dynamics of infliximab and adalimumab in inflammatory bowel disease patients.
    J Crohns Colitis. 2021 Nov 24. pii: 6438514. doi: 10.1093.
    PubMed     Abstract available


  3. BACSUR P, Farkas K, Molnar T
    Outcome of immediate dose optimization of infliximab in inflammatory bowel disease patients.
    J Crohns Colitis. 2021 Nov 18. pii: 6430840. doi: 10.1093.
    PubMed    


  4. GUPTA R, MacIsaac M, Wright EK
    Sleeve gastrectomy in patients with inflammatory bowel disease is not associated with worsening disease.
    J Crohns Colitis. 2021 Nov 17. pii: 6430439. doi: 10.1093.
    PubMed    


  5. D'AMICO F, Magro F, Peyrin-Biroulet L, Danese S, et al
    Positioning filgotinib in the treatment algorithm of moderate to severe ulcerative colitis.
    J Crohns Colitis. 2021 Nov 16. pii: 6429427. doi: 10.1093.
    PubMed     Abstract available


  6. NICHOLSON MR, Alexander E, Ballal S, Davidovics Z, et al
    Efficacy and Outcomes of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Nov 12. pii: 6425925. doi: 10.1093.
    PubMed     Abstract available


  7. VAN ERP LW, Neijenhuis MK, Heida W, Derwig J, et al
    Improving care for recently diagnosed inflammatory bowel disease patients: Lessons learned from a patient-centred, mixed-method study.
    J Crohns Colitis. 2021 Nov 10. pii: 6425110. doi: 10.1093.
    PubMed     Abstract available


  8. CHARPY F, Altwegg R, Debourdeau A
    Disseminated tuberculosis in a patient treated with tofacitinib for ulcerative colitis.
    J Crohns Colitis. 2021 Nov 9. pii: 6424411. doi: 10.1093.
    PubMed    


  9. AGRAWAL M, Zhang X, Brenner EJ, Ungaro RC, et al
    The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry.
    J Crohns Colitis. 2021;15:1877-1884.
    PubMed     Abstract available


  10. LUO J, Xu Z, Noordam R, van Heemst D, et al
    Depression and Inflammatory Bowel Disease: A Bidirectional two-sample Mendelian Randomization Study.
    J Crohns Colitis. 2021 Nov 5. pii: 6421452. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  11. GARRIDO I, Lopes S, Macedo G
    "Safety of COVID-19 vaccination in inflammatory bowel disease patients on biologic therapy".
    J Crohns Colitis. 2021 Oct 30. pii: 6414658. doi: 10.1093.
    PubMed    


  12. LIMA SF, Longman RS
    Eating for Two: Diet and the Microbiome in Ulcerative Colitis.
    J Crohns Colitis. 2021 Oct 27. pii: 6412629. doi: 10.1093.
    PubMed    


  13. FRIEDMAN S, Zegers FD, Jolving LR, Nielsen J, et al
    Postpartum surgical complications in women with inflammatory bowel disease after caesarian section: A Danish nationwide cohort study.
    J Crohns Colitis. 2021 Oct 27. pii: 6412778. doi: 10.1093.
    PubMed     Abstract available


  14. CHARKAOUI M, Hajage D, Tubach F, Laurent B, et al
    Impact of anti-tumor necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: nationwide French cohort study.
    J Crohns Colitis. 2021 Oct 18. pii: 6399096. doi: 10.1093.
    PubMed     Abstract available


  15. RAINE T, Bonovas S, Burisch J, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.
    J Crohns Colitis. 2021 Oct 12. pii: 6390052. doi: 10.1093.
    PubMed    


  16. SPINELLI A, Bonovas S, Burisch J, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
    J Crohns Colitis. 2021 Oct 12. pii: 6390023. doi: 10.1093.
    PubMed     Abstract available


  17. ELFIKY AMI, Ghiboub M, Li Yim AYF, Hageman IL, et al
    Carboxylesterase-1 assisted targeting of HDAC inhibitors to mononuclear myeloid cells in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Oct 11. pii: 6387695. doi: 10.1093.
    PubMed     Abstract available


  18. WALENTYNOWICZ M, van de Pavert I, Fierens L, Coenen S, et al
    Inflammatory Bowel Disease-related Behaviours [IBD-Bx] questionnaire: Development, validation, and prospective associations with fatigue.
    J Crohns Colitis. 2021 Oct 8. pii: 6383644. doi: 10.1093.
    PubMed     Abstract available


  19. JOJART B, Molnar T, Szabo V, Varga A, et al
    Erratum to: P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Oct 7. pii: 6383122. doi: 10.1093.
    PubMed    


  20. ADAMINA M, Fiorino G
    At the Crossroads of Caution and Intervention: Anti-TNF Therapy Prior to Elective CD Surgery.
    J Crohns Colitis. 2021;15:1778-1779.
    PubMed    


  21. MEKORI-DOMACHEVSKY E, Ben-Horin S
    Holistic approach to IBD patients.
    J Crohns Colitis. 2021;15:1782.
    PubMed    


  22. SOOP M, Hancock L, Davies J
    Anti-TNF Therapy Before Intestinal Surgery for Crohn's Disease and the Risks of Postoperative Complications.
    J Crohns Colitis. 2021;15:1777.
    PubMed    


  23. ILVEMARK JFKF, Hansen T, Goodsall TM, Seidelin JB, et al
    Defining transabdominal Intestinal Ultrasound treatment response and remission in Inflammatory Bowel Disease: Systematic review and expert consensus statement.
    J Crohns Colitis. 2021 Oct 6. pii: 6382324. doi: 10.1093.
    PubMed     Abstract available


  24. AARDOOM MA, Klomberg RCW, Kemos P, Ruemmele FM, et al
    The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry.
    J Crohns Colitis. 2021 Oct 2. pii: 6380289. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  25. RICCIUTO A, Lamb CA, Benchimol EI, Walker GJ, et al
    Inflammatory Bowel Disease Clinical Activity Is Associated with COVID-19 Severity Especially in Younger Patients.
    J Crohns Colitis. 2021 Sep 27. pii: 6376474. doi: 10.1093.
    PubMed     Abstract available


  26. CHEN D, Fulmer C, Gordon IO, Syed S, et al
    Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease - What the Clinician Needs to Know.
    J Crohns Colitis. 2021 Sep 24. pii: 6374854. doi: 10.1093.
    PubMed     Abstract available


  27. WONG D, Travis SPL
    Patient-reported Goals in Inflammatory Bowel Disease: What's the Problem?
    J Crohns Colitis. 2021 Sep 21. pii: 6373333. doi: 10.1093.
    PubMed    


  28. SARBAGILI SHABAT C, Scaldaferri F, Zittan E, Hirsch A, et al
    Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial.
    J Crohns Colitis. 2021 Sep 13. pii: 6369227. doi: 10.1093.
    PubMed     Abstract available


  29. PHILLIPS F, Verstockt B, Ribaldone DG, Guerra I, et al
    Diagnosis and outcome of extranodal primary intestinal lymphoma in inflammatory bowel disease: an ECCO CONFER case series.
    J Crohns Colitis. 2021 Sep 11. pii: 6368841. doi: 10.1093.
    PubMed     Abstract available


  30. KIM GH, Lee YC, Kim TJ, Kim ER, et al
    Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study.
    J Crohns Colitis. 2021 Sep 9. pii: 6367800. doi: 10.1093.
    PubMed     Abstract available


  31. BOURGONJE AR, Hu S, Spekhorst LM, Zhernakova DV, et al
    The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Sep 7. pii: 6365883. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  32. BOTS S, Nylund K, Gecse K
    Response to letter to the editor "Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index".
    J Crohns Colitis. 2021 Aug 14. pii: 6352305. doi: 10.1093.
    PubMed    


  33. CARON B, D'Amico F, Danese S, Peyrin-Biroulet L, et al
    Cluster Randomized Trials: Lessons for Inflammatory Bowel Disease Trials.
    J Crohns Colitis. 2021 Aug 14. pii: 6352195. doi: 10.1093.
    PubMed     Abstract available


  34. REUKEN PA, Andreas N, Grunert PC, Glockner S, et al
    T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease.
    J Crohns Colitis. 2021 Aug 11. pii: 6348138. doi: 10.1093.
    PubMed     Abstract available


  35. CROWLEY E, Ma C, Andic M, Feagan BG, et al
    Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Aug 11. pii: 6348023. doi: 10.1093.
    PubMed     Abstract available


  36. TSE CS, Van Citters AD, Ricci B, Freundlich NZ, et al
    Identifying and Predicting the Goals and Concerns Prioritized by Individuals with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Aug 5. pii: 6341120. doi: 10.1093.
    PubMed     Abstract available


  37. CARVELLO M, Bellato V, Maroli A, Hart A, et al
    A multidisciplinary approach to rectal cancer treatment in ulcerative colitis results in high rate of restorative minimally invasive surgery.
    J Crohns Colitis. 2021 Aug 4. pii: 6338719. doi: 10.1093.
    PubMed     Abstract available


  38. PROIETTI E, Fuhler GM, Peppelenbosch MP
    Mycobacterium Avium Subspecies Paratuberculosis Infection and Biological Treatment of IBD: Cause or Consequence?
    J Crohns Colitis. 2021;15:1247-1249.
    PubMed    


  39. WELLENS J, Colombel JF, Satsangi JJ, Wong SY, et al
    SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.
    J Crohns Colitis. 2021;15:1376-1386.
    PubMed     Abstract available


  40. LOCHHEAD P, Khalili H, Sachs MC, Chan AT, et al
    Statin Use and Risk of Inflammatory Bowel Diseases: Authors' Reply.
    J Crohns Colitis. 2021;15:1403-1404.
    PubMed    


    July 2021
  41. SEDANO R, Hogan M, Nguyen TM, Chang J, et al
    Systematic review and Meta-analysis: Clinical, Endoscopic, Histologic and Safety Placebo Rates in Induction and Maintenance trials of Ulcerative Colitis.
    J Crohns Colitis. 2021 Jul 26. pii: 6328606. doi: 10.1093.
    PubMed     Abstract available


  42. PARK SH, Im JP, Park H, Jeong SK, et al
    Clinical features and long-term outcomes of pediatric-onset inflammatory bowel disease in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea.
    J Crohns Colitis. 2021 Jul 26. pii: 6328476. doi: 10.1093.
    PubMed     Abstract available


  43. BOSSUYT P, Pouillon L, Claeys S, D'Haens S, et al
    Ultra-proactive therapeutic drug monitoring of infliximab based on point-of-care-testing in inflammatory bowel disease: results of a pragmatic trial.
    J Crohns Colitis. 2021 Jul 23. pii: 6326544. doi: 10.1093.
    PubMed     Abstract available


  44. CHEE D, Nice R, Hamilton B, Jones E, et al
    Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for therapeutic drug monitoring in patients with inflammatory bowel disease.
    J Crohns Colitis. 2021 Jul 21. pii: 6325142. doi: 10.1093.
    PubMed     Abstract available


  45. DIEZ-OBRERO V, Moratalla-Navarro F, Ibanez-Sanz G, Guardiola J, et al
    Transcriptome-wide association study for inflammatory bowel disease reveals novel candidate susceptibility genes in specific colon subsites and tissue categories.
    J Crohns Colitis. 2021 Jul 21. pii: 6324884. doi: 10.1093.
    PubMed     Abstract available


  46. ZITTAN E, Steinhart AH, Aran H, Milgrom R, et al
    The Toronto Ibd Global Endoscopic Reporting (Tiger) Score: A Single, Easy To Use Endoscopic Score For Both Crohn's Disease And Ulcerative Colitis Patients.
    J Crohns Colitis. 2021 Jul 17. pii: 6323260. doi: 10.1093.
    PubMed     Abstract available


  47. DINALLO V, Di Fusco D, Di Grazia A, Laudisi F, et al
    The deubiquitinating enzyme OTUD5 sustains inflammatory cytokine response in inflammatory bowel disease.
    J Crohns Colitis. 2021 Jul 7. pii: 6316763. doi: 10.1093.
    PubMed     Abstract available


  48. CHOI WT, Salomao M, Zhao L, Alpert L, et al
    Hypermucinous, Goblet Cell Deficient, and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    J Crohns Colitis. 2021 Jul 7. pii: 6316756. doi: 10.1093.
    PubMed     Abstract available


  49. DELISLE M, Wilkens R, Novak KL
    Keeping It Simple: Using Intestinal Ultrasound to Assess Ulcerative Colitis with a Novel UC-Ultrasound Index.
    J Crohns Colitis. 2021 Jul 5. pii: 6315708. doi: 10.1093.
    PubMed    


  50. RESTELLINI S, Lakatos PL
    Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle.
    J Crohns Colitis. 2021;15:1085-1086.
    PubMed    


  51. GUPTA V, Mohsen W, Chapman TP, Satsangi J, et al
    Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021.
    J Crohns Colitis. 2021;15:1211-1221.
    PubMed     Abstract available


  52. DAI C, Jiang M, Huang YH
    Association Between Statin Use and Inflammatory Bowel Diseases.
    J Crohns Colitis. 2021;15:1246.
    PubMed    


  53. COX SR, Clarke H, O'Keeffe M, Dubois P, et al
    Nutrient, fibre and FODMAP intakes and food-related quality of life in patients with inflammatory bowel disease and their relationship with gastrointestinal symptoms of differing aetiologies.
    J Crohns Colitis. 2021 Jul 3. pii: 6314229. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  54. WATANABE S, Hibiya S, Katsukura N, Kitagawa S, et al
    Importance of telomere shortening in the pathogenesis of ulcerative colitis: A new treatment from the aspect of telomeres in intestinal epithelial cells.
    J Crohns Colitis. 2021 Jun 28. pii: 6310549. doi: 10.1093.
    PubMed     Abstract available


  55. GUBATAN J, Rubin SJS, Bai L, Haileselassie Y, et al
    Vitamin D is Associated with alpha4beta7+ Immunophenotypes and Predicts Vedolizumab Therapy Failure in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Jun 28. pii: 6310486. doi: 10.1093.
    PubMed     Abstract available


  56. KUENZIG ME, Bitton A, Carroll MW, Kaplan GG, et al
    Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study.
    J Crohns Colitis. 2021 Jun 27. pii: 6310166. doi: 10.1093.
    PubMed     Abstract available


  57. KIM PH, Yoon HM, Jung AY, Lee JS, et al
    Diagnostic Performance of Diffusion-weighted Imaging for Evaluation of Bowel Inflammation in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2021 Jun 22. pii: 6308099. doi: 10.1093.
    PubMed     Abstract available


  58. GILMORE R, Hilley P, Srinivasan A, Choy M, et al
    Sequential use of high-dose tofacitinib after infliximab salvage therapy in acute severe ulcerative colitis.
    J Crohns Colitis. 2021 Jun 22. pii: 6308093. doi: 10.1093.
    PubMed     Abstract available


  59. ABAKKOUY Y, Cleynen I
    The Promise of Polygenic Risk Scores as a Research Tool to Analyse the Genetics Underlying IBD Phenotypes.
    J Crohns Colitis. 2021;15:877-878.
    PubMed    


  60. ATTAUABI M, Seidelin JB, Burisch J
    Authors' Reply to: 'COVID-19 in the IBD Population: The Need for Correct Nomenclature'.
    J Crohns Colitis. 2021;15:1080.
    PubMed    


  61. GIANOTTI RJ, Cheifetz AS
    Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?
    J Crohns Colitis. 2021 Jun 17. pii: 6301791. doi: 10.1093.
    PubMed    


  62. JOHNSON AM, Harmsen WS, Aniwan S, Tremaine WJ, et al
    Prevalence and Impact of Obesity on Disease-Specific Outcomes in a Population-Based Cohort of Patients with Ulcerative Colitis.
    J Crohns Colitis. 2021 Jun 12. pii: 6297429. doi: 10.1093.
    PubMed     Abstract available


  63. PORTER RJ, Arends MJ, Churchhouse AMD, Din S, et al
    Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines.
    J Crohns Colitis. 2021 Jun 10. pii: 6295922. doi: 10.1093.
    PubMed     Abstract available


  64. GHOSH S, Sanchez Gonzalez Y, Zhou W, Clark R, et al
    Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis.
    J Crohns Colitis. 2021 Jun 9. pii: 6295522. doi: 10.1093.
    PubMed     Abstract available


  65. HERNANDEZ-ROCHA C, Borowski K, Turpin W, Filice M, et al
    Integrative analysis of colonic biopsies from inflammatory bowel disease patients identifies an interaction between microbial bile-acid inducible gene abundance and human Angiopoietin-like 4 gene expression.
    J Crohns Colitis. 2021 Jun 2. pii: 6291049. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  66. FUMERY M, Chatelain D
    Histological Scores in Inflammatory Bowel Disease: A New Kid in the Block.
    J Crohns Colitis. 2021 May 27. pii: 6286012. doi: 10.1093.
    PubMed    


  67. DHERI AK, Kuenzig ME, Mack DR, Murthy SK, et al
    Shifting health care use from hospitalizations and surgeries to outpatient visits in children with inflammatory bowel disease: a population-based cohort study from Ontario, Canada.
    J Crohns Colitis. 2021 May 21. pii: 6279878. doi: 10.1093.
    PubMed     Abstract available


  68. WEISSMAN S, Patel K, Kolli S, Lipcsey M, et al
    Obesity in Inflammatory Bowel Disease is Associated with Early Readmissions characterized by an Increased Systems and Patient-level Burden.
    J Crohns Colitis. 2021 May 17. pii: 6276891. doi: 10.1093.
    PubMed     Abstract available


  69. REZAZADEH ARDABILI A, Creemers RH, van Bodegraven AA
    COVID-19 in the IBD Population: The Need for Correct Nomenclature.
    J Crohns Colitis. 2021;15:872-873.
    PubMed    


  70. BERTE' R, Mazza S, Stefanucci MR, Noviello D, et al
    Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
    J Crohns Colitis. 2021;15:864-868.
    PubMed     Abstract available


  71. REZAZADEH ARDABILI A, Hendrix EMB, Pierik MJ
    Remote Monitoring of Inflammatory Bowel Disease: What Kind of Patient-Reported Questionnaires Should We Use?
    J Crohns Colitis. 2021;15:869-870.
    PubMed    


  72. CROSBY S, Schuh MJ, Farraye FA
    Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab.
    J Crohns Colitis. 2021;15:871.
    PubMed    


  73. ASHTON JJ, Boukas K, Davies J, Stafford IS, et al
    Ileal Transcriptomic Analysis in Paediatric Crohn's Disease Reveals IL17- and NOD-signalling Expression Signatures in Treatment-naive Patients and Identifies Epithelial Cells Driving Differentially Expressed Genes.
    J Crohns Colitis. 2021;15:774-786.
    PubMed     Abstract available


  74. LOCHHEAD P, Khalili H, Sachs MC, Chan AT, et al
    Association Between Statin Use and Inflammatory Bowel Diseases: Results from a Swedish, Nationwide, Population-based Case-control Study.
    J Crohns Colitis. 2021;15:757-765.
    PubMed     Abstract available


  75. KLANG E, Grinman A, Soffer S, Margalit Yehuda R, et al
    Automated Detection of Crohn's Disease Intestinal Strictures on Capsule Endoscopy Images Using Deep Neural Networks.
    J Crohns Colitis. 2021;15:749-756.
    PubMed     Abstract available


  76. MOTTA JP, Palese S, Giorgio C, Chapman K, et al
    Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation.
    J Crohns Colitis. 2021;15:787-799.
    PubMed     Abstract available


  77. NELSON A, Stewart CJ, Kennedy NA, Lodge JK, et al
    The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation.
    J Crohns Colitis. 2021;15:800-812.
    PubMed     Abstract available


  78. MULLER M, D'Amico F, Bonovas S, Danese S, et al
    TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review.
    J Crohns Colitis. 2021;15:840-859.
    PubMed     Abstract available


    April 2021
  79. VAN ERP LW, van Gerven J, Bloem S, Groenen MJM, et al
    Acceptance and perceived control are independently associated with quality of life in inflammatory bowel disease: Introduction of a new segmentation model.
    J Crohns Colitis. 2021 Apr 28. pii: 6257076. doi: 10.1093.
    PubMed     Abstract available


  80. STRAATMIJER T, Biemans VBC, Hoentjen F, de Boer NKH, et al
    Ustekinumab for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.
    J Crohns Colitis. 2021 Apr 28. pii: 6256992. doi: 10.1093.
    PubMed     Abstract available


  81. OUAHED J, Kelsen JR, Spessott WA, Kooshesh K, et al
    Variants in STXBP3 Are Associated With Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation.
    J Crohns Colitis. 2021 Apr 23. pii: 6247960. doi: 10.1093.
    PubMed     Abstract available


  82. SLEIMAN J, Hitawala AA, Cohen B, Falloon K, et al
    Systematic review: Sweet syndrome associated with inflammatory bowel disease.
    J Crohns Colitis. 2021 Apr 23. pii: 6247949. doi: 10.1093.
    PubMed     Abstract available


  83. UNTERWEGER AL, Jensen MO, Giordanetto F, Jogini V, et al
    Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanized Mouse Model of Ulcerative Colitis.
    J Crohns Colitis. 2021 Apr 23. pii: 6247959. doi: 10.1093.
    PubMed     Abstract available


  84. PANES J, Vermeire S, Dubinsky MC, Loftus EV, et al
    Efficacy and Safety of Tofacitinib Retreatment for Ulcerative Colitis After Treatment Interruption: Results From the OCTAVE Clinical Trials.
    J Crohns Colitis. 2021 Apr 22. pii: 6245086. doi: 10.1093.
    PubMed     Abstract available


  85. CHAPARRO M, Garre A, Iborra M, Sierra M, et al
    Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry.
    J Crohns Colitis. 2021 Apr 16. pii: 6228235. doi: 10.1093.
    PubMed     Abstract available


  86. JUNG S, Ye BD, Lee HS, Baek J, et al
    Identification of three novel susceptibility loci for inflammatory bowel disease in Koreans in an extended genome-wide association study.
    J Crohns Colitis. 2021 Apr 14. pii: 6225940. doi: 10.1093.
    PubMed     Abstract available


  87. FUMERY M, Yzet C, Chatelain D, Yzet T, et al
    Colonic strictures in inflammatory bowel disease: epidemiology, complications, and management.
    J Crohns Colitis. 2021 Apr 12. pii: 6222697. doi: 10.1093.
    PubMed     Abstract available


  88. ATTAR A, Branche J, Coron E, Privat J, et al
    An Anti-migration Self-expandable and Removable Metal Stent for Crohn's Disease Strictures: A Nationwide Study From GETAID and SFED.
    J Crohns Colitis. 2021;15:521-528.
    PubMed     Abstract available


  89. NOVAK KL, Nylund K, Maaser C, Petersen F, et al
    Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn's Disease.
    J Crohns Colitis. 2021;15:609-616.
    PubMed     Abstract available


  90. ZHAO J, Wang H, Zhou J, Qian J, et al
    miR-130a-3p, a Preclinical Therapeutic Target for Crohn's Disease.
    J Crohns Colitis. 2021;15:647-664.
    PubMed     Abstract available


  91. DE VRIES LCS, Ghiboub M, van Hamersveld PHP, Welting O, et al
    Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis.
    J Crohns Colitis. 2021;15:617-630.
    PubMed     Abstract available


  92. CON D, Parthasarathy N, Bishara M, Luber RP, et al
    Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn's Disease.
    J Crohns Colitis. 2021;15:583-593.
    PubMed     Abstract available


  93. HUGOT JP, Dumay A, Barreau F, Meinzer U, et al
    Crohn's Disease: Is the Cold Chain Hypothesis Still Hot?
    J Crohns Colitis. 2021;15:678-686.
    PubMed     Abstract available


  94. LUND K, Larsen MD, Knudsen T, Kjeldsen J, et al
    Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn's Disease: a Nationwide Cohort Study.
    J Crohns Colitis. 2021;15:575-582.
    PubMed     Abstract available


  95. VERSTOCKT B, Pouillon L, Bossuyt P
    Tofacitinib and Subacute Pneumonitis: Don't Hold Your Breath.
    J Crohns Colitis. 2021;15:692-693.
    PubMed    


  96. RUTKA M, Pigniczki D, Molnar T
    Tofacitinib Therapy, the Lender of Last Resort.
    J Crohns Colitis. 2021;15:694.
    PubMed    


  97. D'AMICO F, Guillo L, Baumann C, Danese S, et al
    Histological disease activity measured by the Nancy index is associated with long-term outcomes in patients with ulcerative colitis.
    J Crohns Colitis. 2021 Apr 5. pii: 6211061. doi: 10.1093.
    PubMed     Abstract available


  98. NG A
    Clinical efficacy of tofacitinib in moderate to severe ulcerative colitis.
    J Crohns Colitis. 2021 Apr 5. pii: 6211060. doi: 10.1093.
    PubMed    


    March 2021
  99. BRESSLER B, Yarur A, Silverberg MS, Bassel M, et al
    Vedolizumab and Anti-TNFalpha Real-World Outcomes in Biologic-Naive Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
    J Crohns Colitis. 2021 Mar 31. pii: 6205394. doi: 10.1093.
    PubMed     Abstract available


  100. LANG-SCHWARZ C, Angeloni M, Agaimy A, Atreya R, et al
    Validation of the "Inflammatory Bowel Disease - Distribution, Chronicity, Activity (IBD-DCA) Score" for Ulcerative Colitis and Crohn s disease.
    J Crohns Colitis. 2021 Mar 27. pii: 6196021. doi: 10.1093.
    PubMed     Abstract available


  101. PALMIERI C, Muller G, Kroesen AJ, Galata C, et al
    Perianal fistula-associated carcinoma in Crohn s disease: a multicenter retrospective case control study.
    J Crohns Colitis. 2021 Mar 27. pii: 6189787. doi: 10.1093.
    PubMed     Abstract available


  102. NORSA L, Berni Canani R, Duclaux-Loras R, Bequet E, et al
    Inflammatory bowel disease in patients with congenital chloride diarrhoea.
    J Crohns Colitis. 2021 Mar 26. pii: 6189668. doi: 10.1093.
    PubMed     Abstract available


  103. RUDDY J, Taft T, Keszthelyi D
    Gut-Brain Interactions in patients with Inflammatory Bowel Disease (IBD) and the role of Hypnotherapy in Managing Symptoms.
    J Crohns Colitis. 2021 Mar 18. pii: 6175701. doi: 10.1093.
    PubMed    


  104. TORRES J, Halfvarson J, Rodriguez-Lago I, Hedin CRH, et al
    Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD- prediction and prevention of inflammatory bowel disease.
    J Crohns Colitis. 2021 Mar 17. pii: 6175312. doi: 10.1093.
    PubMed     Abstract available


  105. KUCHARZIK T, Ellul P, Greuter T, Rahier JF, et al
    ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Mar 17. pii: 6175313. doi: 10.1093.
    PubMed    


  106. PIOVANI D, Pansieri C, Kotha SRR, Piazza AC, et al
    Ethnic Differences in the Smoking-Related Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2021 Mar 15. pii: 6171987. doi: 10.1093.
    PubMed     Abstract available


  107. VERSTOCKT B, Verstockt S, Abdu Rahiman S, Ke BJ, et al
    Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
    J Crohns Colitis. 2021;15:485-498.
    PubMed     Abstract available


  108. COLLARD MK, Benoist S, Maggiori L, Zerbib P, et al
    A Reappraisal of Outcome of Elective Surgery After Successful Non-Operative Management of an Intra-Abdominal Abscess Complicating Ileocolonic Crohn's Disease: A Subgroup Analysis of a Nationwide Prospective Cohort.
    J Crohns Colitis. 2021;15:409-418.
    PubMed     Abstract available


  109. RICCIUTO A, Mack DR, Huynh HQ, Jacobson K, et al
    Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease.
    J Crohns Colitis. 2021;15:419-431.
    PubMed     Abstract available


  110. MOREAU J, Hammoudi N, Marthey L, Trang-Poisson C, et al
    Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE].
    J Crohns Colitis. 2021;15:432-440.
    PubMed     Abstract available


  111. NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
    Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials.
    J Crohns Colitis. 2021;15:462-470.
    PubMed     Abstract available


  112. BARELLO S, Guida E, Bonanomi A, Menichetti J, et al
    WE-CARE IBD SCORE: Assessing High-quality Care From the Perspective of Patients With Inflammatory Bowel Disease.
    J Crohns Colitis. 2021;15:349-357.
    PubMed     Abstract available


  113. WINTJENS D, Bergey F, Saccenti E, Jeuring S, et al
    Disease Activity Patterns of Crohn's Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort.
    J Crohns Colitis. 2021;15:391-400.
    PubMed     Abstract available


  114. FOURIE S, Norton C, Jackson D, Czuber-Dochan W, et al
    'These discussions aren't happening'. Experiences of people living with inflammatory bowel disease talking about sexual well-being with healthcare professionals.
    J Crohns Colitis. 2021 Mar 4. pii: 6158978. doi: 10.1093.
    PubMed     Abstract available


  115. PAI RK, Hartman DJ, Leighton JA, Shabana PF, et al
    Validated Indices for Histopathologic Activity Predict Development of Colorectal Neoplasia in Ulcerative Colitis.
    J Crohns Colitis. 2021 Mar 4. pii: 6158975. doi: 10.1093.
    PubMed     Abstract available


  116. ATREYA R, Neurath MF
    Can Serum Proteomic Profiling Annunciate Individual Disease Progression in Newly Diagnosed Inflammatory Bowel Disease Patients?
    J Crohns Colitis. 2021 Mar 2. pii: 6156783. doi: 10.1093.
    PubMed    


    February 2021
  117. LUDVIGSSON JF, Olen O, Larsson H, Halfvarson J, et al
    Association between inflammatory bowel disease and psychiatric morbidity and suicide: A Swedish nationwide population-based cohort study with sibling comparisons.
    J Crohns Colitis. 2021 Feb 26. pii: 6153473. doi: 10.1093.
    PubMed     Abstract available


  118. GUILLO L, Peyrin-Biroulet L, Louis E
    Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?
    J Crohns Colitis. 2021 Feb 23. pii: 6146725. doi: 10.1093.
    PubMed    


  119. ALLIN KH, Jacobsen RK, Ungaro RC, Colombel JF, et al
    Bariatric surgery and risk of new-onset inflammatory bowel disease: A nationwide cohort study.
    J Crohns Colitis. 2021 Feb 20. pii: 6145790. doi: 10.1093.
    PubMed     Abstract available


  120. GOETGEBUER RL, Kreijne JE, Aitken CA, Dijkstra G, et al
    Increased risk of high-grade cervical neoplasia in women with inflammatory bowel disease: a case-controlled cohort study.
    J Crohns Colitis. 2021 Feb 20. pii: 6145789. doi: 10.1093.
    PubMed     Abstract available


  121. REINISCH W, Sandborn WJ, Danese S, Hebuterne X, et al
    Long-term safety and efficacy of the anti-MAdCAM-1 monoclonal antibody ontamalimab (SHP647) for the treatment of ulcerative colitis: the open-label study TURANDOT II.
    J Crohns Colitis. 2021 Feb 18. pii: 6144575. doi: 10.1093.
    PubMed     Abstract available


  122. ARAKI T, Mitsuyama K, Yamasaki H, Morita M, et al
    Therapeutic Potential of a Self-Assembling Peptide Hydrogel to Treat Colonic Injuries Associated with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Feb 17. pii: 6141509. doi: 10.1093.
    PubMed     Abstract available


  123. ACKERMANN M, Mucci A, McCabe A, Frei S, et al
    Restored macrophage function ameliorates disease pathophysiology in a mouse model for IL10 receptor deficient very early onset inflammatory bowel disease.
    J Crohns Colitis. 2021 Feb 17. pii: 6141466. doi: 10.1093.
    PubMed     Abstract available


  124. WATANABE S, Nishimura R, Shirasaki T, Katsukura N, et al
    Schlafen 11 is a novel target for mucosal regeneration in Ulcerative Colitis.
    J Crohns Colitis. 2021 Feb 17. pii: 6141476. doi: 10.1093.
    PubMed     Abstract available


  125. ZHAO M, Gonczi L, Lakatos PL, Burisch J, et al
    The burden of inflammatory bowel disease in Europe in 2020.
    J Crohns Colitis. 2021 Feb 14. pii: 6134782. doi: 10.1093.
    PubMed     Abstract available


  126. BARNES EL, Holubar SD, Herfarth HH
    Systematic Review and Meta-Analysis of Outcomes after Ileal Pouch-Anal Anastomosis in Primary Sclerosing Cholangitis-Ulcerative Colitis.
    J Crohns Colitis. 2021 Feb 5. pii: 6129144. doi: 10.1093.
    PubMed     Abstract available


  127. GHOSH S, Iacucci M
    Measuring Patient Experience in Inflammatory Bowel Disease Care: A Key Component of Continuous Quality Improvement.
    J Crohns Colitis. 2021 Feb 5. pii: 6129099. doi: 10.1093.
    PubMed    


    January 2021
  128. RUIGROK RAAA, Collij V, Sureda P, Klaassen MAY, et al
    The composition and metabolic potential of the human small intestinal microbiota within the context of inflammatory bowel disease.
    J Crohns Colitis. 2021 Jan 30. pii: 6123997. doi: 10.1093.
    PubMed     Abstract available


  129. GRIM C, Noble R, Uribe G, Khanipov K, et al
    Impairment of tissue resident mesenchymal stem cells in chronic ulcerative colitis and Crohn's disease.
    J Crohns Colitis. 2021 Jan 28. pii: 6121690. doi: 10.1093.
    PubMed     Abstract available


  130. ALLOCCA M, Bonovas S, Danese S
    Letter to the Editor Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index.
    J Crohns Colitis. 2021 Jan 25. pii: 6119566. doi: 10.1093.
    PubMed    


  131. LOVE BL, Finney CJ, Gaidos JKJ
    Effectiveness of Conjugate and Polysaccharide Pneumococcal Vaccines for Prevention of Severe Pneumococcal Disease Among Inflammatory Bowel Disease Patients.
    J Crohns Colitis. 2021 Jan 25. pii: 6118663. doi: 10.1093.
    PubMed     Abstract available


  132. VERMEIRE S, Chiorean M, Panes J, Peyrin-Biroulet L, et al
    Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study.
    J Crohns Colitis. 2021 Jan 21. pii: 6105062. doi: 10.1093.
    PubMed     Abstract available


  133. ZAIATZ BITTENCOURT V, Jones F, Tosetto M, Doherty GA, et al
    Dysregulation of metabolic pathways in circulating natural killer cells isolated from inflammatory bowel disease patients.
    J Crohns Colitis. 2021 Jan 18. pii: 6103919. doi: 10.1093.
    PubMed     Abstract available


  134. SANDBORN WJ, Feagan BG, Hanauer S, Vermeire S, et al
    Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Results From The Open-Label Extension Of The Randomized, Phase 2 Touchstone Study.
    J Crohns Colitis. 2021 Jan 13. pii: 6092404. doi: 10.1093.
    PubMed     Abstract available


  135. EFFENBERGER M, Reider S, Waschina S, Bronowski C, et al
    Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients.
    J Crohns Colitis. 2021;15:88-98.
    PubMed     Abstract available


  136. LEE S, Kuenzig ME, Ricciuto A, Zhang Z, et al
    Smoking May Reduce the Effectiveness of Anti-TNF Therapies to Induce Clinical Response and Remission in Crohn's Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2021;15:74-87.
    PubMed     Abstract available


  137. THOMAS PWA, Ferwerda G, West RL, Hoentjen F, et al
    Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the Literature.
    J Crohns Colitis. 2021;15:162-164.
    PubMed     Abstract available


  138. WEWER MD, Zhao M, Nordholm-Carstensen A, Weimers P, et al
    The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015.
    J Crohns Colitis. 2021;15:5-13.
    PubMed     Abstract available


  139. DE CAMPOS RJDS, Lucchetti G, Lucchetti ALG, Chebli LA, et al
    Influence of Religiousness and Spirituality on Remission Rate, Mental Health, and Quality of Life of Patients With Active Crohn's Disease: A Longitudinal 2-Year Follow-up Study.
    J Crohns Colitis. 2021;15:55-63.
    PubMed     Abstract available


  140. ZOLLNER A, Schmiderer A, Reider SJ, Oberhuber G, et al
    Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
    J Crohns Colitis. 2021;15:43-54.
    PubMed     Abstract available


  141. SAEVIK F, Eriksen R, Eide GE, Gilja OH, et al
    Development and Validation of a Simple Ultrasound Activity Score for Crohn's Disease.
    J Crohns Colitis. 2021;15:115-124.
    PubMed     Abstract available


  142. D'AMICO F, Nancey S, Danese S, Peyrin-Biroulet L, et al
    A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities.
    J Crohns Colitis. 2021;15:152-161.
    PubMed     Abstract available


  143. KUCHARZIK T, Maaser C, Maconi G
    A Simple Intestinal Ultrasound Score in Crohn's Disease: First Big Step Towards New Paradigms.
    J Crohns Colitis. 2021;15:3-4.
    PubMed    


  144. MAASER C, Kucharzik T, Gecse K
    Is Intestinal Ultrasound Ready to be Used as Standard Monitoring Tool in Daily Practice and as Endpoint in Clinical Trials?
    J Crohns Colitis. 2021;15:1-2.
    PubMed    


  145. DAI C, Jiang M, Huang YH
    Anti-Tubercular Therapy on the Long-Term Disease Course of Patients with Crohn's disease.
    J Crohns Colitis. 2021;15:169.
    PubMed    


  146. BARBERIO B, Segal JP, Quraishi MN, Black CJ, et al
    Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
    J Crohns Colitis. 2021 Jan 12. pii: 6089122. doi: 10.1093.
    PubMed     Abstract available


  147. DE VOOGD F, Wilkens R, Gecse K, Allocca M, et al
    A reliability study - strong inter-observer agreement of an expert panel for intestinal ultrasound in ulcerative colitis.
    J Crohns Colitis. 2021 Jan 9. pii: 6073674. doi: 10.1093.
    PubMed     Abstract available


  148. BOTS S, Nylund K, Lowenberg M, Gecse K, et al
    Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index.
    J Crohns Colitis. 2021 Jan 7. pii: 6067606. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  149. VAN DER SLOOT KWJ, Voskuil MD, Blokzijl T, Dinkla A, et al
    Isotype specific antibody responses to Mycobacterium Avium subspecies Paratuberculosis antigens are associated with the use of biological therapy in Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Dec 30. pii: 6055607. doi: 10.1093.
    PubMed     Abstract available


  150. GUILLO L, D'Amico F, Danese S, Peyrin-Biroulet L, et al
    Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: a systematic literature review.
    J Crohns Colitis. 2020 Dec 24. pii: 6046385. doi: 10.1093.
    PubMed     Abstract available


  151. CROUWEL F, Waaijenberg-Warmenhoven P, Buiter HJC, de Boer NK, et al
    Recurrent COVID-19 in a patient with ulcerative colitis on vedolizumab therapy.
    J Crohns Colitis. 2020 Dec 22. pii: 6044002. doi: 10.1093.
    PubMed    


  152. RAHMI G, Coron E, Perrod G, Levy M, et al
    Probe-based confocal laser endomicroscopy for in vivo assessment of histological healing in ulcerative colitis: development and validation of the ENHANCE index.
    J Crohns Colitis. 2020 Dec 18. pii: 6041240. doi: 10.1093.
    PubMed     Abstract available


  153. BANCIL AS, Sandall AM, Rossi M, Chassaing B, et al
    Food additive emulsifiers and their impact on gut microbiome, permeability and inflammation: mechanistic insights in inflammatory bowel disease.
    J Crohns Colitis. 2020 Dec 18. pii: 6041235. doi: 10.1093.
    PubMed     Abstract available


  154. VENTIN-HOLMBERG R, Eberl A, Saqib S, Korpela K, et al
    Bacterial and fungal profiles as markers of infliximab drug response in inflammatory bowel disease.
    J Crohns Colitis. 2020 Dec 10. pii: 6029424. doi: 10.1093.
    PubMed     Abstract available


  155. VERMEIRE S, Su C, Lawendy N, Kobayashi T, et al
    Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomized RIVETING Trial.
    J Crohns Colitis. 2020 Dec 8. pii: 6027842. doi: 10.1093.
    PubMed     Abstract available


  156. MONSTAD IL, Solberg IC, Cvancarova M, Hovde O, et al
    Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study.
    J Crohns Colitis. 2020 Dec 2. pii: 6015889. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  157. JOHNSON LE, Lee MJ, Turner-Moore T, Grinsted Tate LR, et al
    Systematic review of factors affecting transition readiness skills in patients with inflammatory bowel disease.
    J Crohns Colitis. 2020 Nov 30. pii: 6012510. doi: 10.1093.
    PubMed     Abstract available


  158. HAMAMA-RAZ Y, Nativ S, Hamama L
    Posttraumatic Growth in Inflammatory Bowel Disease Patients: The Role of Illness Cognitions and Physical Quality in Life.
    J Crohns Colitis. 2020 Nov 30. pii: 6012764. doi: 10.1093.
    PubMed     Abstract available


  159. TADBIRI S, Nachury M, Bouhnik Y, Serrero M, et al
    The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease.
    J Crohns Colitis. 2020 Nov 27. pii: 6007776. doi: 10.1093.
    PubMed     Abstract available


  160. WINTHROP KL, Loftus EV Jr, Baumgart DC, Reinisch W, et al
    Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme.
    J Crohns Colitis. 2020 Nov 27. pii: 6007683. doi: 10.1093.
    PubMed     Abstract available


  161. VAN DEN BERGHE N, Verstockt B, Gils A, Sabino J, et al
    Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations.
    J Crohns Colitis. 2020 Nov 27. pii: 6007493. doi: 10.1093.
    PubMed     Abstract available


  162. EVERHOV AH, Bruze G, Soderling J, Askling J, et al
    Women's earnings are more affected by inflammatory bowel disease than men's: a register-based Swedish cohort study.
    J Crohns Colitis. 2020 Nov 27. pii: 6007494. doi: 10.1093.
    PubMed     Abstract available


  163. HOEKMAN DR, Vlieger AM, Stokkers PC, Mahhmod N, et al
    Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent inflammatory bowel disease: a randomized, controlled trial.
    J Crohns Colitis. 2020 Nov 27. pii: 6007495. doi: 10.1093.
    PubMed     Abstract available


  164. AGRAWAL M, Brenner EJ, Zhang X, Colombel JF, et al
    Physician practice patterns on holding inflammatory bowel disease medications due to COVID-19 in the SECURE-IBD registry.
    J Crohns Colitis. 2020 Nov 24. pii: 6000079. doi: 10.1093.
    PubMed     Abstract available


  165. TRAN-MINH ML, Gornet JM, Maillet M, Houze P, et al
    Safety of hydrocortisone premedication discontinuation in patients with inflammatory bowel disease on maintenance therapy with Infliximab: a prospective clinical and pharmacological study.
    J Crohns Colitis. 2020 Nov 18. pii: 5986749. doi: 10.1093.
    PubMed     Abstract available


  166. KALLA R, Adams AT, Bergemalm D, Vatn S, et al
    Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
    J Crohns Colitis. 2020 Nov 17. pii: 5985635. doi: 10.1093.
    PubMed     Abstract available


  167. GALLAGHER K, Catesson A, Griffin JL, Holmes E, et al
    Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review.
    J Crohns Colitis. 2020 Nov 11. pii: 5974408. doi: 10.1093.
    PubMed     Abstract available


  168. KIM MA, Kim YH, Chun J, Lee HS, et al
    The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: A systematic review and meta-analysis.
    J Crohns Colitis. 2020 Nov 11. pii: 5974276. doi: 10.1093.
    PubMed     Abstract available


  169. BARBERIO B, Black CJ, Savarino EV, Ford AC, et al
    Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
    J Crohns Colitis. 2020 Nov 11. pii: 5974124. doi: 10.1093.
    PubMed     Abstract available


  170. SEBASTIAN S, Gonzalez HA, Peyrin-Biroulet L
    Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease.
    J Crohns Colitis. 2020;14:1632-1643.
    PubMed     Abstract available


  171. TURSI A, Papa A
    Impact of Anti-TNFalpha Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14:1646-1647.
    PubMed    


  172. VOSKUIL MD, Spekhorst LM, van der Sloot KWJ, Jansen BH, et al
    Genetic risk scores identify genetic aetiology of inflammatory bowel disease phenotypes.
    J Crohns Colitis. 2020 Nov 6. pii: 5957220. doi: 10.1093.
    PubMed     Abstract available


  173. YOKOYAMA Y, Sawada K, Aoyama N, Yoshimura N, et al
    Erratum to: Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients With Inflammatory Bowel Disease Showing Lost Response to Infliximab.
    J Crohns Colitis. 2020 Nov 6. pii: 5958727. doi: 10.1093.
    PubMed    


    October 2020
  174. MAHMOUD R, van Lieshout C, Frederix GWJ, Jharap B, et al
    Continuation of anti-TNF in patients with Ulcerative Colitis in Remission is not Cost-effective compared to Treatment Withdrawal: a Markov Model.
    J Crohns Colitis. 2020 Oct 30. pii: 5944009. doi: 10.1093.
    PubMed     Abstract available


  175. SIEGEL CA, Christensen B, Kornbluth A, Rosh JR, et al
    Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  176. LEWIN S, Lees C, Regueiro M, Hart A, et al
    International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  177. DE LIMA-KARAGIANNIS A, Juillerat P, Sebastian S, Pedersen N, et al
    Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  178. ABREU MT, Peyrin-Biroulet L
    Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease.
    J Crohns Colitis. 2020;14.
    PubMed    


  179. NG SC, Mak JWY, Hitz L, Chowers Y, et al
    COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  180. DOTAN I, Panaccione R, Kaplan GG, O'Morain C, et al
    Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  181. ALLEZ M, Fleshner P, Gearry R, Lakatos PL, et al
    Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  182. QURAISHI MN, Iqbal TH, Hart AL
    Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet?
    J Crohns Colitis. 2020 Oct 20. pii: 5932516. doi: 10.1093.
    PubMed    


  183. DERIKX LAAP, Lantinga MA, de Jong DJ, van Dop WA, et al
    Clinical Outcomes of Covid-19 in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
    J Crohns Colitis. 2020 Oct 20. pii: 5932316. doi: 10.1093.
    PubMed     Abstract available


  184. BOSSUYT P, Bisschops R, Vermeire S, De Hertogh G, et al
    Variability in the distribution of histological disease activity in the colon of patients with ulcerative colitis.
    J Crohns Colitis. 2020 Oct 14. pii: 5923369. doi: 10.1093.
    PubMed     Abstract available


  185. ATTAUABI M, Poulsen A, Theede K, Pedersen N, et al
    Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease - A Danish prospective population-based cohort study.
    J Crohns Colitis. 2020 Oct 9. pii: 5920382. doi: 10.1093.
    PubMed     Abstract available


  186. ALOI M, Bramuzzo M, Norsa L, Arrigo S, et al
    Disease activity patterns in the first 5 years after diagnosis in children with ulcerative colitis: a population-based study.
    J Crohns Colitis. 2020 Oct 6. pii: 5918427. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  187. MEREDITH J, Khedim CA, Henderson P, Wilson DC, et al
    Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Sep 30. pii: 5913452. doi: 10.1093.
    PubMed     Abstract available


  188. ARHI C, Askari A, Nachiappan S, Bottle A, et al
    Stage at diagnosis and survival of colorectal cancer with or without underlying inflammatory bowel disease: a population-based study.
    J Crohns Colitis. 2020 Sep 29. pii: 5912977. doi: 10.1093.
    PubMed     Abstract available


  189. CHAPARRO M, Garre A, Mesonero F, Rodriguez C, et al
    Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.
    J Crohns Colitis. 2020 Sep 24. pii: 5910901. doi: 10.1093.
    PubMed     Abstract available


  190. MULLER M, Broseus J, Feugier P, Thieblemont C, et al
    Characteristics Of Lymphoma In Patients With Inflammatory Bowel Disease: A Systematic Review.
    J Crohns Colitis. 2020 Sep 19. pii: 5908884. doi: 10.1093.
    PubMed     Abstract available


  191. DRUVEFORS E, Landerholm K, Hammar U, Myrelid P, et al
    Impaired fertility in Women with Inflammatory Bowel Disease: A National Cohort Study from Sweden.
    J Crohns Colitis. 2020 Sep 19. pii: 5908862. doi: 10.1093.
    PubMed     Abstract available


  192. VENY M, Garrido-Trigo A, Corraliza AM, Masamunt MC, et al
    Dissecting common and unique effects of anti-alpha4beta7 and anti-tumor necrosis factor treatment in ulcerative colitis.
    J Crohns Colitis. 2020 Sep 14. pii: 5905252. doi: 10.1093.
    PubMed     Abstract available


  193. MERLI AM, Vieujean S, Massot C, Bletard N, et al
    Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis.
    J Crohns Colitis. 2020 Sep 13. pii: 5905032. doi: 10.1093.
    PubMed     Abstract available


  194. CONLEY TE, Probert C, Subramanian S
    Prevalence of COVID-19 Symptoms among Inflammatory Bowel Disease Patients Treated with Biological Agents.
    J Crohns Colitis. 2020 Sep 11. pii: 5904432. doi: 10.1093.
    PubMed    


  195. JANGI S, Holmer AK, Dulai PS, Boland BS, et al
    Risk of Relapse in Patients with Ulcerative Colitis with Persistent Endoscopic Healing: A Durable Treatment Endpoint.
    J Crohns Colitis. 2020 Sep 10. pii: 5903914. doi: 10.1093.
    PubMed     Abstract available


  196. MAK JWY, Ho CLT, Wong K, Cheng TY, et al
    Epidemiology and Natural History of Elderly-onset inflammatory bowel disease: Results from a territory-wide Hong Kong IBD registry.
    J Crohns Colitis. 2020 Sep 10. pii: 5903917. doi: 10.1093.
    PubMed     Abstract available


  197. VALTER M, Verstockt S, Finalet Ferreiro JA, Cleynen I, et al
    Extracellular vesicles in inflammatory bowel disease: small particles, big players.
    J Crohns Colitis. 2020 Sep 9. pii: 5903363. doi: 10.1093.
    PubMed     Abstract available


  198. WASMANN KA, van der Does de Willebois EM, Koens L, Duijvestein M, et al
    The Impact of Rectal Stump Inflammation After Subtotal Colectomy on Pouch Outcomes in Ulcerative Colitis Patients.
    J Crohns Colitis. 2020 Sep 9. pii: 5903251. doi: 10.1093.
    PubMed     Abstract available


  199. MAGRO F, Estevinho MM, Dias CC, Correia L, et al
    Clinical, endoscopic and histological outcomes in induction of moderate-to-severe ulcerative colitis: a systematic review with meta-analysis.
    J Crohns Colitis. 2020 Sep 8. pii: 5902904. doi: 10.1093.
    PubMed     Abstract available


  200. MAGRO F, Estevinho MM
    Newborn Congenital Abnormalities and Inflammatory Bowel Disease: Unveiling an Unexplored Relationship.
    J Crohns Colitis. 2020;14:1033-1034.
    PubMed    


    August 2020
  201. CAMILLERI M
    Ten Reasons to Think about Bile Acids in Managing Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Aug 31. pii: 5899784. doi: 10.1093.
    PubMed    


  202. MATSUOKA K, Igarashi A, Sato N, Isono Y, et al
    Trends in corticosteroid prescriptions for ulcerative colitis and factors associated with long-term corticosteroid use: analysis using Japanese claims data from 2006 to 2016.
    J Crohns Colitis. 2020 Aug 26. pii: 5897347. doi: 10.1093.
    PubMed     Abstract available


  203. OLESEN SW, Gerardin Y
    Re-evaluating the evidence for fecal microbiota transplantation "super-donors" in inflammatory bowel disease.
    J Crohns Colitis. 2020 Aug 18. pii: 5893677. doi: 10.1093.
    PubMed     Abstract available


  204. SOOD A, Singh A, Mahajan R, Midha V, et al
    Clinical Predictors of response to Faecal Microbiota Transplantation in patients with active ulcerative colitis.
    J Crohns Colitis. 2020 Aug 9. pii: 5890140. doi: 10.1093.
    PubMed     Abstract available


  205. REINISCH W, Danese S, Peyrin-Biroulet L, Loftus EV, et al
    Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic.
    J Crohns Colitis. 2020 Aug 7. pii: 5885159. doi: 10.1093.
    PubMed    


    July 2020
  206. GHOSH S, Sensky T, Casellas F, Rioux LC, et al
    A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients with Ulcerative Colitis Using the Pictorial Representation of Illness and Self-Measure Tool.
    J Crohns Colitis. 2020 Jul 29. pii: 5877457. doi: 10.1093.
    PubMed     Abstract available


  207. MAGRO F, Rahier JF, Abeu C, MacMahon E, et al
    Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce.
    J Crohns Colitis. 2020 Jul 29. pii: 5877458. doi: 10.1093.
    PubMed     Abstract available


  208. MANTA R, Zullo A, Telesca A, Castellani D, et al
    Endoscopic Submucosal Dissection for visible dysplasia treatment in ulcerative colitis patients: cases series and systematic review of literature.
    J Crohns Colitis. 2020 Jul 25. pii: 5876412. doi: 10.1093.
    PubMed     Abstract available


  209. FUMERY M, Matias C, Brochot E
    Seroconversion of immunoglobulins to SARS-CoV2 in patients with inflammatory bowel disease patients treated by biologics.
    J Crohns Colitis. 2020 Jul 22. pii: 5875101. doi: 10.1093.
    PubMed    


  210. PRIVITERA G, Onali S, Pugliese D, Renna S, et al
    Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Jul 17. pii: 5872608. doi: 10.1093.
    PubMed     Abstract available


  211. ALLOCCA M, Furfaro F, Fiorino G, Peyrin-Biroulet L, et al
    Point-of-care ultrasound in Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Jul 17. pii: 5872609. doi: 10.1093.
    PubMed     Abstract available


  212. BLACKWELL J, Saxena S, Jayasooriya N, Bottle A, et al
    Prevalence and duration of gastrointestinal symptoms before diagnosis of Inflammatory Bowel Disease and predictors of timely specialist review: a population-based study.
    J Crohns Colitis. 2020 Jul 15. pii: 5871943. doi: 10.1093.
    PubMed     Abstract available


  213. CROUWEL F, Buiter HJC, de Boer NK
    Gut microbiota-driven drug metabolism in inflammatory bowel disease.
    J Crohns Colitis. 2020 Jul 11. pii: 5870328. doi: 10.1093.
    PubMed     Abstract available


  214. TARGOWNIK LE, Benchimol EI, Bernstein CN, Singh H, et al
    Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications.
    J Crohns Colitis. 2020 Jul 10. pii: 5869652. doi: 10.1093.
    PubMed     Abstract available


  215. MARGALIT-YEHUDA R, Ben-Horin S
    Bottom-up: Can Trans-anal Rectal Resection Improve Outcomes in Ulcerative Colitis Patients Undergoing Proctocolectomy and Ileo-anal Pouch Anastomosis?
    J Crohns Colitis. 2020;14:724-725.
    PubMed    


  216. PARRA RS, Feitosa MR, Feres O
    Segmental Colectomy: An Alternative for Ulcerative Colitis in Endoscopic Remission?
    J Crohns Colitis. 2020 Jul 6. pii: 5868033. doi: 10.1093.
    PubMed    


  217. GOODSALL TM, Nguyen TM, Parker CE, Ma C, et al
    Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease.
    J Crohns Colitis. 2020 Jul 2. pii: 5866421. doi: 10.1093.
    PubMed     Abstract available


  218. SULTAN K, Swaminath A
    From Bad to Worse: The Relationship Between Opioid Use and Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Jul 2. pii: 5866377. doi: 10.1093.
    PubMed    


    June 2020
  219. TSENG CH
    Metformin use is associated with a lower risk of inflammatory bowel disease in patients with type 2 diabetes mellitus.
    J Crohns Colitis. 2020 Jun 30. pii: 5865444. doi: 10.1093.
    PubMed     Abstract available


  220. GOODSALL TM, Costello SP, Bryant RV
    Histological Healing in Ulcerative Colitis: Near Enough Is Not Good Enough.
    J Crohns Colitis. 2020 Jun 30. pii: 5865087. doi: 10.1093.
    PubMed    


  221. ZHOU M, He J, Shi Y, Liu X, et al
    ABIN3 negatively regulates necroptosis-induced intestinal inflammation through recruiting A20 and restricting the ubiquitination of RIPK3 in inflammatory bowel disease.
    J Crohns Colitis. 2020 Jun 30. pii: 5864883. doi: 10.1093.
    PubMed     Abstract available


  222. KALLA R, Adams AT, Ventham NT, Kennedy NA, et al
    Whole blood profiling of T-cell derived miRNA allows the development of prognostic models in inflammatory bowel disease.
    J Crohns Colitis. 2020 Jun 29. pii: 5864785. doi: 10.1093.
    PubMed     Abstract available


  223. SCHREINER P, Mueller NJ, Fehr J, Maillard MH, et al
    Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know.
    J Crohns Colitis. 2020 Jun 27. pii: 5864104. doi: 10.1093.
    PubMed     Abstract available


  224. LIGHTNER AL, Vogler S, McMichael J, Jia X, et al
    Dysplastic Progression to Adenocarcinoma is Equivalent in Ulcerative Colitis and Crohn's disease.
    J Crohns Colitis. 2020 Jun 27. pii: 5864008. doi: 10.1093.
    PubMed     Abstract available


  225. SCHREIBER S, Dignass A, Rogge A, Rubin DT, et al
    Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic is not a Responsible Act.
    J Crohns Colitis. 2020 Jun 25. pii: 5862397. doi: 10.1093.
    PubMed     Abstract available


  226. D'AMICO F, Peyrin-Biroulet L, Danese S
    JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis.
    J Crohns Colitis. 2020 Jun 24. pii: 5862030. doi: 10.1093.
    PubMed    


  227. MUKHERJEE S, Beresford B, Atkin K, Sebastian S, et al
    The need for culturally competent care within gastroenterology services: Evidence from research with adults of South Asian origin living with inflammatory bowel disease.
    J Crohns Colitis. 2020 Jun 23. pii: 5861668. doi: 10.1093.
    PubMed     Abstract available


  228. VAN DER SLOOT KWJ, Weersma RK, Alizadeh BZ, Dijkstra G, et al
    Identification of environmental risk factors associated with the development of Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Jun 23. pii: 5861037. doi: 10.1093.
    PubMed     Abstract available


  229. GRUNERT PC, Reuken PA, Stallhofer J, Teich N, et al
    Inflammatory Bowel Disease in the COVID-19 Pandemic - the Patients' Perspective.
    J Crohns Colitis. 2020 Jun 20. pii: 5860461. doi: 10.1093.
    PubMed     Abstract available


  230. D'AMICO F, Baumann C, Rousseau H, Danese S, et al
    Phase I, II and III Trials in Inflammatory Bowel Diseases: A Practical Guide for the Non-specialist.
    J Crohns Colitis. 2020;14:710-718.
    PubMed     Abstract available


  231. SOMERS M, Bossuyt P, Ferrante M, Peeters H, et al
    Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14:680-685.
    PubMed     Abstract available


  232. VON MARTELS JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, et al
    Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].
    J Crohns Colitis. 2020;14:595-607.
    PubMed     Abstract available


  233. FAUNY M, D'Amico F, Bonovas S, Netter P, et al
    Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review.
    J Crohns Colitis. 2020;14:688-693.
    PubMed     Abstract available


  234. ZHOU C, Wu XR, Liu HS, Liu XH, et al
    Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner.
    J Crohns Colitis. 2020;14:654-668.
    PubMed     Abstract available


  235. VALE RODRIGUES R, Sladek M, Katsanos K, van der Woude CJ, et al
    Diagnosis and Outcome of Oesophageal Crohn's Disease.
    J Crohns Colitis. 2020;14:624-629.
    PubMed     Abstract available


  236. AL NABHANI Z, Berrebi D, Martinez-Vinson C, Montcuquet N, et al
    Nod2 Protects the Gut From Experimental Colitis Spreading to Small Intestine.
    J Crohns Colitis. 2020;14:669-679.
    PubMed     Abstract available


  237. ZHAO M, Burisch J
    The Sooner the Better? Cost-effectiveness of Early Biological Therapy in Patients With Crohn's Disease.
    J Crohns Colitis. 2020;14:573-574.
    PubMed    


  238. EDER P, Dobrowolska A, Rydzewska G
    Historical Upheavals and Eponyms in Crohn's Disease-Is There Any Relation?
    J Crohns Colitis. 2020;14:719.
    PubMed    


  239. WEISSMAN S, Goldowsky A, Mehta TI, Sciarra MA, et al
    Are Quality Metrics in Inflammatory Bowel Disease Rooted on Substantial Quality Evidence? A Systematic Review.
    J Crohns Colitis. 2020 Jun 16. pii: 5858213. doi: 10.1093.
    PubMed     Abstract available


  240. REINISCH W, Danese S, Peyrin-Biroulet L, Loftus EV, et al
    Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic.
    J Crohns Colitis. 2020 Jun 10. pii: 5855532. doi: 10.1093.
    PubMed     Abstract available


  241. MAGRO F, Doherty G, Peyrin-Biroulet L, Svrcek M, et al
    ECCO Position Paper: Harmonisation of the approach to Ulcerative Colitis Histopathology.
    J Crohns Colitis. 2020 Jun 6. pii: 5854301. doi: 10.1093.
    PubMed     Abstract available


  242. FRONTALI A, Cohen L, Bridoux V, Myrelid P, et al
    Segmental colectomy for ulcerative colitis: is there a place in selected patients without active colitis ? An international multicentric retrospective study in 72 patients.
    J Crohns Colitis. 2020 Jun 4. pii: 5851522. doi: 10.1093.
    PubMed     Abstract available


  243. FRIEDMAN S, Nielsen J, Jolving LR, Nohr EA, et al
    Long-term motor and cognitive function in the children of women with inflammatory bowel disease.
    J Crohns Colitis. 2020 Jun 4. pii: 5851419. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  244. NEHRA AK, Sheedy SP, Wells ML, VanBuren WM, et al
    Imaging Findings of Ileal Inflammation at Computed Tomography and Magnetic Resonance Enterography: What do They Mean When Ileoscopy and Biopsy are Negative?
    J Crohns Colitis. 2020;14:455-464.
    PubMed     Abstract available


  245. DANIELOU M, Sarter H, Pariente B, Fumery M, et al
    Natural History of Perianal Fistulising Lesions in Patients With Elderly-onset Crohn's Disease: A Population-based Study.
    J Crohns Colitis. 2020;14:501-507.
    PubMed     Abstract available


  246. PILLAI N, Lupatsch JE, Dusheiko M, Schwenkglenks M, et al
    Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn's Disease using Real-World Data.
    J Crohns Colitis. 2020;14:490-500.
    PubMed     Abstract available


  247. CONDAMINA M, Diaz E, Jamart C, Loget J, et al
    Severe Attack of Henoch-Schonlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn's Disease.
    J Crohns Colitis. 2020;14:538-542.
    PubMed     Abstract available


  248. SPARROW MP, Papamichael K, Ward MG, Riviere P, et al
    Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response.
    J Crohns Colitis. 2020;14:542-556.
    PubMed     Abstract available


  249. RODRIGUEZ-LAGO I, Gisbert JP
    The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn's Disease.
    J Crohns Colitis. 2020;14:557-566.
    PubMed     Abstract available


  250. DHALIWAL J, Walters TD, Mack DR, Huynh HQ, et al
    Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network.
    J Crohns Colitis. 2020;14:445-454.
    PubMed     Abstract available


  251. MADARAME A, Kimura H, Kunisaki R
    Successful Treatment With Ustekinumab for Enterocutaneous Fistulas in Crohn's Disease.
    J Crohns Colitis. 2020;14:569-570.
    PubMed    


  252. CHATEAU T, Angioi K, Peyrin-Biroulet L
    Two Cases of Successful Ustekinumab Treatment for Non-infectious Uveitis Associated With Crohn's Disease.
    J Crohns Colitis. 2020;14:571.
    PubMed    


  253. PARK SH, Kim HJ, Lee CK, Song EM, et al
    Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease.
    J Crohns Colitis. 2020 May 17. pii: 5838422. doi: 10.1093.
    PubMed     Abstract available


  254. VARIOLA A, Zanolin E, Cipriano G, Macchioni P, et al
    The IBIS-Q (IBd Identification of Spondyloarthrytis Questionnaire): a novel tool to detect both Axial and Peripheral Arthritis in Inflammatory Bowel Disease patients.
    J Crohns Colitis. 2020 May 15. pii: 5837772. doi: 10.1093.
    PubMed     Abstract available


  255. LIANG G, Conrad MA, Kelsen JR, Kessler LR, et al
    The dynamics of the stool virome in very early onset inflammatory bowel disease.
    J Crohns Colitis. 2020 May 14. pii: 5837025. doi: 10.1093.
    PubMed     Abstract available


  256. CHAPMAN S, Sibelli A, St-Clair Jones A, Forbes A, et al
    Personalised Adherence Support for Maintenance Treatment of Inflammatory Bowel Disease: A Tailored Digital Intervention to Change Adherence-related Beliefs and Barriers.
    J Crohns Colitis. 2020 May 7. pii: 5831700. doi: 10.1093.
    PubMed     Abstract available


  257. HORIO Y, Uchino M, Bando T, Sasaki H, et al
    Incidence, Risk Factors, and Outcomes of Cancer of the Anal Transitional Zone with Ulcerative Colitis..
    J Crohns Colitis. 2020 May 4. pii: 5828994. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  258. BOIVINEAU L, Le Mehaute A, Roblin X
    Prospective evaluation of cytomegalovirus time-course kinetics in colonic biopsies from patients with moderate-to-severe ulcerative colitis following infliximab treatment: a prospective study.
    J Crohns Colitis. 2020 Apr 28. pii: 5826392. doi: 10.1093.
    PubMed    


  259. FLANAGAN E, Wright EK, Begun J, Bryant RV, et al
    Monitoring Inflammatory Bowel Disease in Pregnancy using Gastrointestinal Ultrasonography.
    J Crohns Colitis. 2020 Apr 28. pii: 5826347. doi: 10.1093.
    PubMed     Abstract available


  260. ZHANG B, Gulati A, Alipour O, Shao L, et al
    Relapse from deep remission after therapeutic de-escalation in inflammatory bowel disease: a systematic review and meta-analysis.
    J Crohns Colitis. 2020 Apr 26. pii: 5825450. doi: 10.1093.
    PubMed     Abstract available


  261. PHILLIPS FM, Verstockt B, Sebastian S, Ribaldone DG, et al
    Inflammatory cutaneous lesions in inflammatory bowel disease treated with Vedolizumab or Ustekinumab: an ECCO CONFER multicentre case series.
    J Crohns Colitis. 2020 Apr 22. pii: 5823596. doi: 10.1093.
    PubMed     Abstract available


  262. PEYRIN-BIROULET C, D'Amico F, Peyrin-Biroulet L
    Will COVID-19 infection be less severe in ulcerative colitis than in Crohn's patients due to a lower rate of smokers?
    J Crohns Colitis. 2020 Apr 18. pii: 5821493. doi: 10.1093.
    PubMed    


  263. HONAP S, Chee D, Chapman TP, Patel M, et al
    Real-World Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multi-Centre UK Experience.
    J Crohns Colitis. 2020 Apr 13. pii: 5819381. doi: 10.1093.
    PubMed     Abstract available


  264. CARDINALE CJ, March ME, Lin X, Liu Y, et al
    Regulation of Janus Kinase 2 by an Inflammatory Bowel Disease Causal Non-coding Single Nucleotide Polymorphism.
    J Crohns Colitis. 2020 Apr 9. pii: 5818372. doi: 10.1093.
    PubMed     Abstract available


  265. CHRISTENSEN B, Hanauer SB, Gibson PR, Turner JR, et al
    Segmental Histologic Normalisation Occurs in Ulcerative Colitis but does not Improve Clinical Outcomes.
    J Crohns Colitis. 2020 Apr 8. pii: 5817864. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  266. BAI X, Yang H, Qian J
    COVID-19 outbreak and inflammatory bowel disease management: a questionnaire survey from realistic practice.
    J Crohns Colitis. 2020 Mar 28. pii: 5812999. doi: 10.1093.
    PubMed    


  267. MONTELEONE G, Ardizzone S
    Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?
    J Crohns Colitis. 2020 Mar 26. pii: 5811674. doi: 10.1093.
    PubMed     Abstract available


  268. VAN ANDEL EM, Koopmann BDM, Crouwel F, Noomen CG, et al
    Systematic review of development and content validity of patient-reported outcome measures in Inflammatory Bowel Disease: do we measure what we measure?
    J Crohns Colitis. 2020 Mar 25. pii: 5811405. doi: 10.1093.
    PubMed     Abstract available


  269. FIORINO G, Allocca M, Furfaro F, Gilardi D, et al
    Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience.
    J Crohns Colitis. 2020 Mar 24. pii: 5811431. doi: 10.1093.
    PubMed     Abstract available


  270. CALAFAT M, Manosa M, Mesonero F, Guardiola J, et al
    Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: a nationwide study from the ENEIDA registry.
    J Crohns Colitis. 2020 Mar 23. pii: 5810964. doi: 10.1093.
    PubMed     Abstract available


  271. IACUCCI M, Cannatelli R, Gui XS, Zardo D, et al
    Assessment of endoscopic healing by using advanced technologies reflects histologic healing in ulcerative colitis.
    J Crohns Colitis. 2020 Mar 23. pii: 5810912. doi: 10.1093.
    PubMed     Abstract available


  272. SCHREIBER S, Hanauer SB, Sandborn WJ, Barrett K, et al
    Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
    J Crohns Colitis. 2020 Mar 17. pii: 5807996. doi: 10.1093.
    PubMed     Abstract available


  273. SLEVIN SM, Garner LC, Lahiff C, Tan M, et al
    Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis.
    J Crohns Colitis. 2020 Mar 16. pii: 5807948. doi: 10.1093.
    PubMed     Abstract available


  274. DORRINGTON AM, Selinger CP, Parkes GC, Smith M, et al
    The historical role and contemporary use of corticosteroids in inflammatory bowel disease.
    J Crohns Colitis. 2020 Mar 14. pii: 5805149. doi: 10.1093.
    PubMed     Abstract available


  275. BARTKO J, Reichardt B, Kocijan R, Klaushofer K, et al
    Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk after Hip Fracture.
    J Crohns Colitis. 2020 Mar 14. pii: 5805150. doi: 10.1093.
    PubMed     Abstract available



  276. Retraction: An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference i
    J Crohns Colitis. 2020;14:428.
    PubMed    


  277. YOKOYAMA Y, Sawada K, Aoyama N, Yoshimura N, et al
    Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients with Inflammatory Bowel Disease Showing Lost Response to Infliximab.
    J Crohns Colitis. 2020 Mar 13. pii: 5804700. doi: 10.1093.
    PubMed     Abstract available


  278. ANNESE V
    Small Bowel Adenocarcinoma in Crohn's Disease: An Underestimated Risk?
    J Crohns Colitis. 2020;14:285-286.
    PubMed    


  279. CARBONNEL F, Svrcek M
    Progress in the Molecular and Histological Dissection of Crohn's Disease-associated Small Bowel Adenocarcinomas.
    J Crohns Colitis. 2020;14:283-284.
    PubMed    


  280. DELATTRE C, Lewis A, Kirchgesner J, Nion-Larmurier I, et al
    Impact of Aphthous Colitis at Diagnosis on Crohn's Disease Outcomes.
    J Crohns Colitis. 2020;14:342-350.
    PubMed     Abstract available


  281. FELWICK RK, Dingley GJR, Martinez-Nunez R, Sanchez-Elsner T, et al
    MicroRNA23a Overexpression in Crohn's Disease Targets Tumour Necrosis Factor Alpha Inhibitor Protein 3, Increasing Sensitivity to TNF and Modifying the Epithelial Barrier.
    J Crohns Colitis. 2020;14:381-392.
    PubMed     Abstract available


  282. FIELDS AC, Hu FY, Lu P, Irani J, et al
    Small Bowel Adenocarcinoma: Is There a Difference in Survival for Crohn's Versus Sporadic Cases?
    J Crohns Colitis. 2020;14:303-308.
    PubMed     Abstract available


  283. BORREN NZ, Tan W, Colizzo FP, Luther J, et al
    Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study.
    J Crohns Colitis. 2020;14:309-315.
    PubMed     Abstract available


  284. PIOVANI D, Danese S, Peyrin-Biroulet L, Bonovas S, et al
    Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study.
    J Crohns Colitis. 2020;14:323-331.
    PubMed     Abstract available


  285. FRANZE E, Monteleone I, Laudisi F, Rizzo A, et al
    Cadherin-11 Is a Regulator of Intestinal Fibrosis.
    J Crohns Colitis. 2020;14:406-417.
    PubMed     Abstract available


  286. VERSTOCKT B, Mertens E, Dreesen E, Outtier A, et al
    Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naive and Anti-TNF Exposed IBD Patients.
    J Crohns Colitis. 2020;14:332-341.
    PubMed     Abstract available


  287. POREDSKA K, Kunovsky L, Marek F, Kala Z, et al
    The Influence of Microscopic Inflammation at Resection Margins on Early Postoperative Endoscopic Recurrence After Ileocaecal Resection for Crohn's Disease.
    J Crohns Colitis. 2020;14:361-368.
    PubMed     Abstract available


  288. ARPA G, Grillo F, Giuffrida P, Nesi G, et al
    Separation of Low- Versus High-grade Crohn's Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis.
    J Crohns Colitis. 2020;14:295-302.
    PubMed     Abstract available


  289. PELLINO G, Vinci D, Signoriello G, Kontovounisios C, et al
    Long-Term Bowel Function and Fate of the Ileal Pouch After Restorative Proctocolectomy in Patients With Crohn's Disease: A Systematic Review With Meta-Analysis and Metaregression.
    J Crohns Colitis. 2020;14:418-427.
    PubMed     Abstract available


  290. LIAO X, Li G, McBride R, Houldsworth J, et al
    Clinicopathological and Molecular Characterisation of Crohn's Disease-associated Small Bowel Adenocarcinomas.
    J Crohns Colitis. 2020;14:287-294.
    PubMed     Abstract available


  291. SANDBORN WJ, Nguyen DD, Beattie DT, Brassil P, et al
    Development of gut-selective pan-Janus kinase inhibitor TD-1473 for ulcerative colitis: A translational medicine program.
    J Crohns Colitis. 2020 Mar 11. pii: 5803305. doi: 10.1093.
    PubMed     Abstract available


  292. SEVERYNS T, Kirchgesner J, Lambert J, Thieblemont C, et al
    Prognosis of lymphoma in patients with known Inflammatory Bowel Disease: a French multicentre cohort study.
    J Crohns Colitis. 2020 Mar 11. pii: 5803309. doi: 10.1093.
    PubMed     Abstract available


  293. BARNHOORN MC, Hakuno SK, Bruckner RS, Rogler G, et al
    Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Mar 11. pii: 5803221. doi: 10.1093.
    PubMed     Abstract available


  294. LEFEVRE PLC, Vande Casteele N
    Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Mar 11. pii: 5803222. doi: 10.1093.
    PubMed     Abstract available


  295. LAUBE R, Yau Y, Selinger CP, Seow CH, et al
    Knowledge and attitudes towards pregnancy in females with Inflammatory Bowel Disease - an international, multi-centre study.
    J Crohns Colitis. 2020 Mar 11. pii: 5803333. doi: 10.1093.
    PubMed     Abstract available


  296. SHAH SC, Itzkowitz SH
    Reappraising risk factors for inflammatory bowel disease-associated neoplasia: Implications for colonoscopic surveillance in IBD.
    J Crohns Colitis. 2020 Mar 9. pii: 5801093. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  297. ROBERTS SE, Thorne K, Thapar N, Broekaert I, et al
    A systematic review and meta analysis of paediatric inflammatory bowel disease incidence and prevalence across Europe.
    J Crohns Colitis. 2020 Feb 28. pii: 5770946. doi: 10.1093.
    PubMed     Abstract available


  298. NOHR EA, Nielsen J, Norgard BM, Friedman S, et al
    Sexual health in women with inflammatory bowel disease in the Danish National Birth Cohort.
    J Crohns Colitis. 2020 Feb 27. pii: 5760869. doi: 10.1093.
    PubMed     Abstract available


  299. MOURAD FH, Hashash JG, Kariyawasam VC, Leong RW, et al
    Ulcerative Colitis and Cytomegalovirus Infection: From A to Z.
    J Crohns Colitis. 2020 Feb 27. pii: 5760718. doi: 10.1093.
    PubMed     Abstract available


  300. SOLA TAPIAS N, Vergnolle N, Denadai-Souza A, Barreau F, et al
    The interplay between genetic risk factors and proteolytic dysregulation in the pathophysiology of inflammatory bowel disease.
    J Crohns Colitis. 2020 Feb 22. pii: 5748295. doi: 10.1093.
    PubMed     Abstract available


  301. MEUNIER L, Clerc C, Meszaros M
    Use of Tofacitinib for ulcerative colitis in a liver transplant patient.
    J Crohns Colitis. 2020 Feb 19. pii: 5740228. doi: 10.1093.
    PubMed    


  302. SHAH R, Hoffman GR, El-Dallal M, Goldowsky AM, et al
    Is Therapeutic Drug Monitoring for Anti-Tumor Necrosis Factor Agents in Adults with Inflammatory Bowel Disease Ready for Standard of Care?: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2020 Feb 17. pii: 5736596. doi: 10.1093.
    PubMed     Abstract available


  303. VERMEIRE S, Lukas M, Magro F, Adsul S, et al
    Vedolizumab Efficacy, Safety, and Pharmacokinetics with Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients with Crohn's Disease or Ulcerative Colitis.
    J Crohns Colitis. 2020 Feb 15. pii: 5736390. doi: 10.1093.
    PubMed     Abstract available


  304. ZADRO V, Santus P, Maconi G
    Ulcerative Colitis: not only gut.
    J Crohns Colitis. 2020 Feb 14. pii: 5735761. doi: 10.1093.
    PubMed    


  305. SCHREIBER S
    Lack of Efficacy in Crohn's Disease Prompts Unplanned Interim Analysis and Termination of Study in Ulcerative Colitis.
    J Crohns Colitis. 2020;14:282.
    PubMed    


  306. SIEGMUND B
    Are Serum-Based Markers Going to Replace Faecal Neutrophil Markers in Ulcerative Colitis?
    J Crohns Colitis. 2020;14:151-152.
    PubMed    


  307. ADAMINA M, Bonovas S, Raine T, Spinelli A, et al
    ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
    J Crohns Colitis. 2020;14:155-168.
    PubMed     Abstract available


  308. MAGRO F, Lopes J, Borralho P, Lopes S, et al
    Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.
    J Crohns Colitis. 2020;14:169-175.
    PubMed     Abstract available


  309. WASMANN KA
    Complications While Waiting for IBD Surgery-Short Report.
    J Crohns Colitis. 2020;14:277-280.
    PubMed     Abstract available


  310. KEITA AV, Alkaissi LY, Holm EB, Heil SDS, et al
    Enhanced E. coli LF82 Translocation through the Follicle-associated Epithelium in Crohn's Disease is Dependent on Long Polar Fimbriae and CEACAM6 expression, and Increases Paracellular Permeability.
    J Crohns Colitis. 2020;14:216-229.
    PubMed     Abstract available


  311. AGRAWAL M, Burisch J, Colombel JF, C Shah S, et al
    Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations.
    J Crohns Colitis. 2020;14:267-273.
    PubMed     Abstract available


  312. PIERRE N, Salee C, Massot C, Bletard N, et al
    Proteomics Highlights Common and Distinct Pathophysiological Processes Associated with Ileal and Colonic Ulcers in Crohn's Disease.
    J Crohns Colitis. 2020;14:205-215.
    PubMed     Abstract available


  313. COSTA-MOREIRA P, Lopes S, Santos AL, Pedrosa AF, et al
    Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
    J Crohns Colitis. 2020;14:274-276.
    PubMed     Abstract available


  314. KOTWANI P, Terdiman J, Lewin S
    Tofacitinib for rescue therapy in acute severe ulcerative colitis: a real-world experience.
    J Crohns Colitis. 2020 Feb 5. pii: 5727212. doi: 10.1093.
    PubMed     Abstract available


  315. OSTVIK AE, Svendsen TD, Granlund AVB, Doseth B, et al
    Intestinal epithelial cells express immunomodulatory ISG15 during active ulcerative colitis and Crohn's disease.
    J Crohns Colitis. 2020 Feb 5. pii: 5727513. doi: 10.1093.
    PubMed     Abstract available


  316. LO B, Holm JP, Vester-Andersen MK, Bendtsen F, et al
    Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease - a Danish population-based inception cohort with 10 years of follow-up.
    J Crohns Colitis. 2020 Feb 4. pii: 5722012. doi: 10.1093.
    PubMed     Abstract available


  317. QURAISHI MN, Acharjee A, Beggs AD, Horniblow R, et al
    A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways.
    J Crohns Colitis. 2020 Feb 4. pii: 5722016. doi: 10.1093.
    PubMed     Abstract available


  318. AGRAWAL M, Kim ES, Colombel JF
    JAK inhibitors safety in ulcerative colitis: practical implications.
    J Crohns Colitis. 2020 Feb 1. pii: 5719575. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  319. DE JONG ME, Smits LJT, van Ruijven B, den Broeder N, et al
    Increased discontinuation rates of anti-TNF therapy in elderly inflammatory bowel disease patients.
    J Crohns Colitis. 2020 Jan 24. pii: 5715073. doi: 10.1093.
    PubMed     Abstract available


  320. MAGRO F, Lopes J, Borralho P, Dias CC, et al
    Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis.
    J Crohns Colitis. 2020 Jan 22. pii: 5713474. doi: 10.1093.
    PubMed     Abstract available


  321. MARTIN A, Nachury M, Peyrin-Biroulet L, Bouhnik Y, et al
    Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study.
    J Crohns Colitis. 2020 Jan 13. pii: 5701423. doi: 10.1093.
    PubMed     Abstract available


  322. NICOLAIDES S, Vasudevan A, Van Langenberg D
    Medical Management of Infliximab Failure in Acute Severe Ulcerative Colitis.
    J Crohns Colitis. 2020 Jan 13. pii: 5701450. doi: 10.1093.
    PubMed    


  323. AUGER N, Cote-Daigneault J, Bilodeau-Bertrand M, Arbour L, et al
    Inflammatory bowel disease and risk of birth defects in offspring.
    J Crohns Colitis. 2020 Jan 7. pii: 5697329. doi: 10.1093.
    PubMed     Abstract available


  324. LUKAS M, Malickova K, Kolar M, Bortlik M, et al
    Switching from originator adalimumab to the biosimilar SB5 in patients with inflammatory bowel disease: Short-term experience from a single tertiary clinical center.
    J Crohns Colitis. 2020 Jan 6. pii: 5697282. doi: 10.1093.
    PubMed     Abstract available


  325. SCOTT FI, Luo M, Shah Y, Lasch K, et al
    Identification of the most cost effective position of vedolizumab among the available biologic drugs for the treatment of ulcerative colitis.
    J Crohns Colitis. 2020 Jan 4. pii: 5696657. doi: 10.1093.
    PubMed     Abstract available


  326. HOMMEL C, Pillet S, Rahier JF
    Comment on: 'Resolution of CMV Infection in the Bowel on Vedolizumab Therapy'.
    J Crohns Colitis. 2020;14:148-149.
    PubMed    


  327. BIEMANS VBC, van der Meulen-de Jong AE, van der Woude CJ, Lowenberg M, et al
    Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study.
    J Crohns Colitis. 2020;14:33-45.
    PubMed     Abstract available


  328. VERDIER J, Breunig IR, Ohse MC, Roubrocks S, et al
    Faecal Micro-RNAs in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14:110-117.
    PubMed     Abstract available


  329. BARNHOORN MC, Wasser MNJM, Roelofs H, Maljaars PWJ, et al
    Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
    J Crohns Colitis. 2020;14:64-70.
    PubMed     Abstract available


  330. LEVINE A, Chanchlani N, Hussey S, Ziv-Baran T, et al
    Complicated Disease and Response to Initial Therapy Predicts Early Surgery in Paediatric Crohn's Disease: Results From the Porto Group GROWTH Study.
    J Crohns Colitis. 2020;14:71-78.
    PubMed     Abstract available


  331. BRAGA-NETO MB, Gaballa JM, Bamidele AO, Sarmento OF, et al
    Deregulation of Long Intergenic Non-coding RNAs in CD4+ T Cells of Lamina Propria in Crohn's Disease Through Transcriptome Profiling.
    J Crohns Colitis. 2020;14:96-109.
    PubMed     Abstract available


  332. HANAUER SB, Sandborn WJ, Feagan BG, Gasink C, et al
    IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
    J Crohns Colitis. 2020;14:23-32.
    PubMed     Abstract available


  333. TORRES J, Bonovas S, Doherty G, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
    J Crohns Colitis. 2020;14:4-22.
    PubMed    


  334. TRAVIS S
    IM-UNITI at Three Years: Stellar Stelara(R) or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
    J Crohns Colitis. 2020;14:1-3.
    PubMed    


    December 2019
  335. HARRIS RE, Curtis L, Hegde V, Garrick V, et al
    A decade of Varicella screening within a paediatric inflammatory bowel disease population.
    J Crohns Colitis. 2019 Dec 31. pii: 5691246. doi: 10.1093.
    PubMed     Abstract available


  336. FERRANTE M, Sabino J
    Efficacy of anti-JAK inhibitors in ulcerative colitis.
    J Crohns Colitis. 2019 Dec 27. pii: 5687770. doi: 10.1093.
    PubMed     Abstract available


  337. KOBAYASHI T, Uda A, Udagawa E, Hibi T, et al
    Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis.
    J Crohns Colitis. 2019 Dec 23. pii: 5684917. doi: 10.1093.
    PubMed     Abstract available


  338. FLEMING C, Mohan H, Coffey JC
    Should we Resect the Mesentery in Ileocolic Crohn's Disease?-A Response to 'A Warning About the Role of Extended Mesenteric Resection in Crohn's Disease Recurrence'.
    J Crohns Colitis. 2019;13:1584.
    PubMed    


  339. MARK-CHRISTENSEN A, Erichsen R, Veres K, Laurberg S, et al
    Extracolonic cancer risk after total colectomy for inflammatory bowel disease: A population-based cohort study.
    J Crohns Colitis. 2019 Dec 7. pii: 5666210. doi: 10.1093.
    PubMed     Abstract available


  340. CHARILAOU P, Mohapatra S, Joshi T, Devani K, et al
    Opioid Use Disorder Increases 30-Day Readmission Risk in Inflammatory Bowel Disease Hospitalizations: a Nationwide Matched Analysis.
    J Crohns Colitis. 2019 Dec 5. pii: 5658684. doi: 10.1093.
    PubMed     Abstract available


  341. REES WD, Stahl M, Jacobson K, Bressler B, et al
    Enteroids derived from inflammatory bowel disease patients display dysregulated endoplasmic reticulum stress pathways, leading to differential inflammatory responses and dendritic cell maturation.
    J Crohns Colitis. 2019 Dec 4. pii: 5651304. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  342. GISBERT JP, Chaparro M
    Predictors of primary response to biologic treatment (anti-TNF, vedolizumab and ustekinumab) in patients with inflammatory bowel disease: from basic science to clinical practice.
    J Crohns Colitis. 2019 Nov 28. pii: 5645127. doi: 10.1093.
    PubMed     Abstract available


  343. SHARMA U, Olson RK, Erhart FN, Zhang L, et al
    Prescription opioid induce gut dysbiosis and exacerbate colitis in a murine model of Inflammatory Bowel Disease.
    J Crohns Colitis. 2019 Nov 27. pii: 5644048. doi: 10.1093.
    PubMed     Abstract available


  344. PAPAMICHAEL K, Cheifetz AS
    Proactive adalimumab monitoring in inflammatory bowel disease: current data and future perspectives.
    J Crohns Colitis. 2019 Nov 25. pii: 5639767. doi: 10.1093.
    PubMed    


  345. KING D, Rees J, Mytton J, Harvey P, et al
    The Outcomes of Emergency Admissions with Ulcerative Colitis between 2007 and 2017 in England.
    J Crohns Colitis. 2019 Nov 12. pii: 5623020. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  346. AKSAN A, Wohlrath M, Iqbal TH, Dignass A, et al
    Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease.
    J Crohns Colitis. 2019 Oct 28. pii: 5608095. doi: 10.1093.
    PubMed     Abstract available


  347. VAVRICKA SR, Greuter T
    Simple and Simply the Best? Dublin in the European Spotlight.
    J Crohns Colitis. 2019;13:1363-1364.
    PubMed    


  348. PEPPELENBOSCH MP, Parikh K, Fuhler G
    Cannabinoid Signal Transduction Explains Disconnect of Cannabis Effects in Experimental and Clinical Colitis.
    J Crohns Colitis. 2019;13:1479.
    PubMed    


  349. SMEETS FGM, Liedorp PR, van der Poel M, Miclea RL, et al
    Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn's Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature.
    J Crohns Colitis. 2019;13:1470-1473.
    PubMed     Abstract available


  350. KLAASSEN MAY, Imhann F, Collij V, Fu J, et al
    Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.
    J Crohns Colitis. 2019;13:1439-1449.
    PubMed     Abstract available


  351. MOHAMMADI A, Kelly OB, Smith MI, Kabakchiev B, et al
    Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy Subjects.
    J Crohns Colitis. 2019;13:1459-1469.
    PubMed     Abstract available


  352. LIEFFERINCKX C, Verstockt B, Gils A, Noman M, et al
    Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study.
    J Crohns Colitis. 2019;13:1401-1409.
    PubMed     Abstract available


  353. NOBLE A, Durant L, Hoyles L, McCartney AL, et al
    Deficient Resident Memory T-Cell and Cd8 T-Cell Response to Commensals in Inflammatory Bowel Disease.
    J Crohns Colitis. 2019 Oct 26. pii: 5607395. doi: 10.1093.
    PubMed     Abstract available


  354. ADLER J
    Can we Improve the Prognostic Value of Phenotype at Inflammatory Bowel Disease Diagnosis?
    J Crohns Colitis. 2019 Oct 22. pii: 5602619. doi: 10.1093.
    PubMed    


  355. CHANDRASINGHE P, Carvello M, Wasmann K, Foppa C, et al
    Transanal ileal pouch-anal anastomosis for ulcerative colitis has comparable long-term functional outcomes to transabdominal approach: a multicentre comparative study.
    J Crohns Colitis. 2019 Oct 22. pii: 5602131. doi: 10.1093.
    PubMed     Abstract available


  356. SCHMITT H, Ulmschneider J, Billmeier U, Vieth M, et al
    The TLR9 agonist cobitolimod induces IL10 producing wound healing macrophages and regulatory T cells in ulcerative colitis.
    J Crohns Colitis. 2019 Oct 20. pii: 5601212. doi: 10.1093.
    PubMed     Abstract available


  357. DE BRUYN M, Ringold R, Martens E, Ferrante M, et al
    The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor.
    J Crohns Colitis. 2019 Oct 19. pii: 5601149. doi: 10.1093.
    PubMed     Abstract available


  358. ELIADOU E, Moleiro J, Ribaldone DG, Astegiano M, et al
    Interstitial and Granulomatous lung disease in inflammatory bowel disease patients.
    J Crohns Colitis. 2019 Oct 11. pii: 5585570. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  359. SMITH RL, Taylor KM, Friedman AB, Gibson RN, et al
    Systematic review: Clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis.
    J Crohns Colitis. 2019 Sep 28. pii: 5575710. doi: 10.1093.
    PubMed     Abstract available


  360. SCHOEPFER A, Santos J, Fournier N, Schibli S, et al
    Systematic Analysis of the Impact of Diagnostic Delay on Bowel Damage in Paediatric Versus Adult Onset Crohn's Disease.
    J Crohns Colitis. 2019;13:1334-1342.
    PubMed     Abstract available


  361. SINGH K, Al Khoury A, Kurti Z, Gonczi L, et al
    High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
    J Crohns Colitis. 2019;13:1343-1350.
    PubMed     Abstract available


  362. BOLIN K, Hertervig E, Louis E
    The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's Disease.
    J Crohns Colitis. 2019;13:1323-1333.
    PubMed     Abstract available


  363. JERUC J, Drobne D, Zidar N
    Diffuse Colitis Cystica Profunda in Crohn's Disease: A Potential Diagnostic Pitfall.
    J Crohns Colitis. 2019;13:1362.
    PubMed    


  364. FREI R, Fournier N, Zeitz J, Scharl M, et al
    Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study.
    J Crohns Colitis. 2019;13:1292-1301.
    PubMed     Abstract available


  365. PACHLER FR, Toft G, Bisgaard T, Laurberg S, et al
    Use and Success of In Vitro Fertilisation Following Restorative Proctocolectomy and Ileal Pouch-anal Anastomosis. A Nationwide 17-year Cohort Study.
    J Crohns Colitis. 2019;13:1283-1286.
    PubMed     Abstract available


  366. GODNY L, Maharshak N, Reshef L, Goren I, et al
    Fruit Consumption is Associated with Alterations in Microbial Composition and Lower Rates of Pouchitis.
    J Crohns Colitis. 2019;13:1265-1272.
    PubMed     Abstract available


  367. VANDE CASTEELE N, Baert F, Bian S, Dreesen E, et al
    Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study.
    J Crohns Colitis. 2019;13:1248-1256.
    PubMed     Abstract available


  368. GALAZZO G, Tedjo DI, Wintjens DSJ, Savelkoul PHM, et al
    Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease.
    J Crohns Colitis. 2019;13:1273-1282.
    PubMed     Abstract available


  369. ADAMINA M, Gerasimidis K, Sigall-Boneh R, Zmora O, et al
    Perioperative dietary therapy in inflammatory bowel disease.
    J Crohns Colitis. 2019 Sep 24. pii: 5573284. doi: 10.1093.
    PubMed     Abstract available


  370. CHAPUY L, Bsat M, Rubio M, Harvey F, et al
    Transcriptomic analysis and High dimensional phenotypic mapping of mononuclear phagocytes in mesenteric lymph nodes reveal differences between ulcerative colitis and Crohn's disease.
    J Crohns Colitis. 2019 Sep 21. pii: 5572419. doi: 10.1093.
    PubMed     Abstract available


  371. RASELLI T, Wyss A, Gonzalez Alvarado MN, Weder B, et al
    The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis.
    J Crohns Colitis. 2019;13:1186-1200.
    PubMed     Abstract available


  372. GLICK LR, Sossenheimer PH, Ollech JE, Cohen RD, et al
    Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study.
    J Crohns Colitis. 2019;13:1158-1162.
    PubMed     Abstract available


  373. GONCZI L, Kurti Z, Verdon C, Reinglas J, et al
    Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre.
    J Crohns Colitis. 2019;13:1138-1147.
    PubMed     Abstract available


  374. BRIOT C, Faure P, Parmentier AL, Nachury M, et al
    Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study.
    J Crohns Colitis. 2019;13:1121-1130.
    PubMed     Abstract available


  375. KHOURY T, Daher S, Massarwa M, Hakimian D, et al
    A Validated Score Assessing the Risk of an Intra-Abdominal Abscess in Patients with Crohn's Disease Presenting at the Emergency Department.
    J Crohns Colitis. 2019;13:1131-1137.
    PubMed     Abstract available


  376. HISAMATSU T, Matsumoto T, Watanabe K, Nakase H, et al
    Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study].
    J Crohns Colitis. 2019;13:1097-1104.
    PubMed     Abstract available


  377. WEISSHOF R, Ollech JE, El Jurdi K, Yvellez OV, et al
    Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
    J Crohns Colitis. 2019;13:1105-1110.
    PubMed     Abstract available


  378. RAWA-GOLEBIEWSKA A, Lenarcik M, Zagorowicz E
    Resolution of CMV Infection in the Bowel on Vedolizumab Therapy.
    J Crohns Colitis. 2019;13:1234-1235.
    PubMed    


  379. ROJO E, Chaparro M, Garcia-Buey L
    Efficacy and Safety of Glecaprevir/pibrentasvir in a Patient With HCV-Induced Porphyria Cutanea Tarda Receiving Vedolizumab for Crohn s Disease.
    J Crohns Colitis. 2019 Sep 17. pii: 5570723. doi: 10.1093.
    PubMed    


    August 2019
  380. LEE C, Hong SN, Paik NY, Kim TJ, et al
    CD1d Modulates Colonic Inflammation in NOD2-/- Mice by Altering the Intestinal Microbial Composition Comprising Acetatifactor muris.
    J Crohns Colitis. 2019;13:1081-1091.
    PubMed     Abstract available


  381. KANSAL S, Catto-Smith AG, Boniface K, Thomas S, et al
    The Microbiome in Paediatric Crohn's Disease-A Longitudinal, Prospective, Single-Centre Study.
    J Crohns Colitis. 2019;13:1044-1054.
    PubMed     Abstract available


  382. BORREN NZ, Luther J, Colizzo FP, Garber JG, et al
    Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2019;13:990-995.
    PubMed     Abstract available


  383. POTDAR AA, Li D, Haritunians T, VanDussen KL, et al
    Ileal Gene Expression Data from Crohn's Disease Small Bowel Resections Indicate Distinct Clinical Subgroups.
    J Crohns Colitis. 2019;13:1055-1066.
    PubMed     Abstract available


  384. BUISSON A, Mak WY, Andersen MJ, Lei D, et al
    Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
    J Crohns Colitis. 2019;13:1012-1024.
    PubMed     Abstract available


    July 2019
  385. NEARY PM, Aiello AC, Stocchi L, Shawki S, et al
    High-Risk Ileocolic Anastomoses for Crohn's Disease: When Is Diversion Indicated?
    J Crohns Colitis. 2019;13:856-863.
    PubMed     Abstract available


  386. DEUTSCHMANN C, Sowa M, Murugaiyan J, Roesler U, et al
    Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease.
    J Crohns Colitis. 2019;13:894-904.
    PubMed     Abstract available


  387. PEKOW J, Hernandez K, Meckel K, Deng Z, et al
    IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon Cancers.
    J Crohns Colitis. 2019;13:884-893.
    PubMed     Abstract available


  388. BISHU S, El Zaatari M, Hayashi A, Hou G, et al
    CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor alpha in Active Crohn's Disease.
    J Crohns Colitis. 2019;13:905-915.
    PubMed     Abstract available


  389. VERSTOCKT B, Dreesen E, Noman M, Outtier A, et al
    Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates.
    J Crohns Colitis. 2019;13:864-872.
    PubMed     Abstract available


  390. VERSTOCKT S, De Hertogh G, Van der Goten J, Verstockt B, et al
    Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease.
    J Crohns Colitis. 2019;13:916-930.
    PubMed     Abstract available


  391. PIGNEUR B, Lepage P, Mondot S, Schmitz J, et al
    Mucosal Healing and Bacterial Composition in Response to Enteral Nutrition Vs Steroid-based Induction Therapy-A Randomised Prospective Clinical Trial in Children With Crohn's Disease.
    J Crohns Colitis. 2019;13:846-855.
    PubMed     Abstract available


  392. YZET C, Brazier F, Fumery M
    Post-operative Entero-cutaneous Fistula Closure by Over-the-Scope Clip in Crohn's Disease.
    J Crohns Colitis. 2019;13:954-955.
    PubMed    


  393. KEEFER L
    The Time Has Come to Integrate Behavioural Health Services Into IBD Centres.
    J Crohns Colitis. 2019;13:817-818.
    PubMed    


  394. LAMB CA, Mansfield JC, Kirby JA, Keir ME, et al
    The Importance of Molecular Immune Investigation in Therapeutic Clinical Development for Biomarker Assessment.
    J Crohns Colitis. 2019;13:956-957.
    PubMed    


    May 2019
  395. PANACCIONE R, Lofberg R, Rutgeerts P, Sandborn WJ, et al
    Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies.
    J Crohns Colitis. 2019;13:725-734.
    PubMed     Abstract available


  396. BURR NE, Hall B, Hamlin PJ, Selinger CP, et al
    Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.
    J Crohns Colitis. 2019;13:693-701.
    PubMed     Abstract available


  397. BARNHOORN MC, Van Halteren AGS, Van Pel M, Molendijk I, et al
    Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn's Fistulas: A Case Report.
    J Crohns Colitis. 2019;13:807-811.
    PubMed     Abstract available


    April 2019
  398. MAO R, Chen YJ, Chen BL, Xie XH, et al
    Intra-Cavitary Contrast-Enhanced Ultrasound: A Novel Radiation-Free Method for Detecting Abscess-Associated Penetrating Disease in Crohn's Disease.
    J Crohns Colitis. 2019;13:593-599.
    PubMed     Abstract available


  399. CHAVANNES M, Martinez-Vinson C, Hart L, Kaniki N, et al
    Management of Paediatric Patients With Medically Refractory Crohn's Disease Using Ustekinumab: A Multi-Centred Cohort Study.
    J Crohns Colitis. 2019;13:578-584.
    PubMed     Abstract available


  400. OSTROWSKI J, Dabrowska M, Lazowska I, Paziewska A, et al
    Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2019;13:626-633.
    PubMed     Abstract available


  401. RIPOLLES T, Martinez-Perez MJ, Paredes JM, Vizuete J, et al
    The Role of Intravenous Contrast Agent in the Sonographic Assessment of Crohn's Disease Activity: Is Contrast Agent Injection Necessary?
    J Crohns Colitis. 2019;13:585-592.
    PubMed     Abstract available


  402. CORRALIZA AM, Ricart E, Lopez-Garcia A, Carme Masamunt M, et al
    Differences in Peripheral and Tissue Immune Cell Populations Following Haematopoietic Stem Cell Transplantation in Crohn's Disease Patients.
    J Crohns Colitis. 2019;13:634-647.
    PubMed     Abstract available


  403. KAKUTA Y, Kawai Y, Naito T, Hirano A, et al
    A Genome-wide Association Study Identifying RAP1A as a Novel Susceptibility Gene for Crohn's Disease in Japanese Individuals.
    J Crohns Colitis. 2019;13:648-658.
    PubMed     Abstract available


  404. HAIN E, Maggiori L, Orville M, Treton X, et al
    Diverting Stoma for Refractory Ano-perineal Crohn's Disease: Is It Really Useful in the Anti-TNF Era? A Multivariate Analysis in 74 Consecutive Patients.
    J Crohns Colitis. 2019;13:572-577.
    PubMed     Abstract available


  405. HEDIN CRH, Vavricka SR, Stagg AJ, Schoepfer A, et al
    The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.
    J Crohns Colitis. 2019;13:541-554.
    PubMed     Abstract available


  406. ROOSENBOOM B, van Lochem EG, Horjus Talabur Horje CS
    AlphaE Expression in Inflammatory Bowel Disease: a Biomarker for the use of Etrolizumab?
    J Crohns Colitis. 2019;13:671.
    PubMed    


    March 2019
  407. D'HOORE A
    Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's Disease: Immediate Surgical Implications!
    J Crohns Colitis. 2019;13:271-272.
    PubMed    


  408. DE GROOF EJ, van der Meer JHM, Tanis PJ, de Bruyn JR, et al
    Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's Disease.
    J Crohns Colitis. 2019;13:285-293.
    PubMed     Abstract available


    February 2019
  409. MAASER C
    New ECCO Guidelines Generation.
    J Crohns Colitis. 2019;13:141.
    PubMed    


  410. SZVARCA D, Borum ML
    Don't Be Late on Latent TB: Inconsistent Tuberculosis Screening in IBD Patients on Biologics.
    J Crohns Colitis. 2019;13:270.
    PubMed    


    January 2019
  411. WIERINGA JW, van der Woude CJ
    Editorial: The Effect of Thiopurines on Offspring.
    J Crohns Colitis. 2019;13:1-2.
    PubMed    


  412. SZVARCA D, Greenfest A, Borum M
    WebIBD: How Much Can We Trust Medical Information Online?
    J Crohns Colitis. 2019;13:138.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: